• Vertigo is a sensation of motion or spinning that is often described as dizziness:

    Vertigo:

    Definition: Vertigo is a specific type of dizziness characterized by a sensation of spinning or movement, either of the person or their surroundings.
    Symptoms: Spinning sensation, balance problems, nausea, vomiting, nystagmus (involuntary eye movement), sweating, hearing loss, and ringing in the ears (tinnitus).
    Causes:
    Benign Paroxysmal Positional Vertigo (BPPV): Caused by small calcium particles (canaliths) clumping in the inner ear canals.
    Meniere's Disease: Involves excessive fluid in the inner ear.
    Vestibular Neuritis: Inflammation of the vestibular nerve, often due to viral infections.
    Labyrinthitis: Inner ear infection affecting both hearing and balance.
    Migraine: Vestibular migraines can cause vertigo without headache.
    Other Causes: Head injuries, strokes, brain tumors, certain medications, and alcohol.

    Dizziness:

    Definition: Dizziness is a broader term encompassing various sensations such as feeling faint, woozy, weak, or unsteady.

    Types of Dizziness:

    Lightheadedness: A feeling of near-fainting or fainting, often associated with hypotension.
    Disequilibrium: A sense of imbalance or unsteadiness without the spinning sensation.
    Presyncope: Sensation of imminent fainting, often related to cardiovascular issues.
    Non-specific Dizziness: General disorientation or a feeling of wooziness.

    Causes:

    Inner Ear Problems: Issues like BPPV, Meniere's disease, or vestibular neuritis.
    Circulatory Problems: Blood pressure issues, heart conditions, or dehydration.
    Neurological Conditions: Migraines, multiple sclerosis, Parkinson’s disease.
    Medications: Blood pressure medications, sedatives, antidepressants, and certain antibiotics.
    Anxiety Disorders: Panic attacks or generalized anxiety can cause dizziness.
    Other Causes: Hypoglycemia, anemia, infections, overheating, and dehydration.

    Prevention:

    Manage Underlying Conditions: Treat cardiovascular issues, diabetes, and anxiety.
    Avoid Triggers: Such as rapid head movements, certain visual stimuli, and known dietary triggers.
    Regular Check-ups: Particularly for individuals with chronic conditions affecting balance.
    Understanding vertigo and dizziness involves recognizing the wide array of potential causes and symptoms and seeking appropriate medical evaluation and treatment tailored to the underlying issue.

    Taking these steps can help manage vertigo and dizziness more effectively, improve your quality of life, and reduce the risk of complications. Don't wait—take action today to regain control of your balance and well-being. Visit Here: https://tinyurl.com/5dywcvpc

    #vertigo, #dizziness, #cardiovascular, #anxiety, #AnxietyDisorders
    Vertigo is a sensation of motion or spinning that is often described as dizziness: Vertigo: Definition: Vertigo is a specific type of dizziness characterized by a sensation of spinning or movement, either of the person or their surroundings. Symptoms: Spinning sensation, balance problems, nausea, vomiting, nystagmus (involuntary eye movement), sweating, hearing loss, and ringing in the ears (tinnitus). Causes: Benign Paroxysmal Positional Vertigo (BPPV): Caused by small calcium particles (canaliths) clumping in the inner ear canals. Meniere's Disease: Involves excessive fluid in the inner ear. Vestibular Neuritis: Inflammation of the vestibular nerve, often due to viral infections. Labyrinthitis: Inner ear infection affecting both hearing and balance. Migraine: Vestibular migraines can cause vertigo without headache. Other Causes: Head injuries, strokes, brain tumors, certain medications, and alcohol. Dizziness: Definition: Dizziness is a broader term encompassing various sensations such as feeling faint, woozy, weak, or unsteady. Types of Dizziness: Lightheadedness: A feeling of near-fainting or fainting, often associated with hypotension. Disequilibrium: A sense of imbalance or unsteadiness without the spinning sensation. Presyncope: Sensation of imminent fainting, often related to cardiovascular issues. Non-specific Dizziness: General disorientation or a feeling of wooziness. Causes: Inner Ear Problems: Issues like BPPV, Meniere's disease, or vestibular neuritis. Circulatory Problems: Blood pressure issues, heart conditions, or dehydration. Neurological Conditions: Migraines, multiple sclerosis, Parkinson’s disease. Medications: Blood pressure medications, sedatives, antidepressants, and certain antibiotics. Anxiety Disorders: Panic attacks or generalized anxiety can cause dizziness. Other Causes: Hypoglycemia, anemia, infections, overheating, and dehydration. Prevention: Manage Underlying Conditions: Treat cardiovascular issues, diabetes, and anxiety. Avoid Triggers: Such as rapid head movements, certain visual stimuli, and known dietary triggers. Regular Check-ups: Particularly for individuals with chronic conditions affecting balance. Understanding vertigo and dizziness involves recognizing the wide array of potential causes and symptoms and seeking appropriate medical evaluation and treatment tailored to the underlying issue. Taking these steps can help manage vertigo and dizziness more effectively, improve your quality of life, and reduce the risk of complications. Don't wait—take action today to regain control of your balance and well-being. Visit Here: https://tinyurl.com/5dywcvpc #vertigo, #dizziness, #cardiovascular, #anxiety, #AnxietyDisorders
    0 Comments 0 Shares 4022 Views
  • Destroying Super Immunity & Getting Rid of That Annoying Cough
    Dr. Syed Haider

    I made it through multiple upper respiratory illnesses affecting my wife and kids over the last year without getting sick myself.

    The biggest difference maker seemed to be spending a lot of time outdoors in sunny Puerto Rico.

    It’s not just about the vitamin D that you get in the afternoons, it’s also about the lack of blue light toxicity you get the rest of the day from glass filtered indoor sunlight (or artificial lights).

    Blue light in the visible spectrum needs to be balanced by the naturally present infrared and UV spectrum in natural sunlight. Unfortunately both are blocked by typical window glass.


    Anyway, my long run of seemingly bulletproof immunity came to an inglorious end when I finally succumbed to what had been plaguing my nuclear family for a couple weeks: it began with a tickle in my throat, then progressed to a mild sore throat, stuffy and runny nose, bad a cough, and fatigue. It was rough going for a day or two. Hard to sleep with all the coughing.

    My post mortem analysis of what went wrong: I visited family overseas, where they live in an apartment full of artificial light and not much direct sun. I did my best to get outside, but couldnt do it anywhere near as much as I used to at home. Then (perhaps more or less important?) I started including once a week “stress test days” (nee cheat days) on my carnivore diet. That turned into a general laxity during my regular carnivore diet days, including eating out and being exposed to ubiquitous seed oils.

    Then one day I was enjoying my meat dish at a local restaurant and decided spur of the moment (always a mistake) to try the side dish I would have normally skipped. Unfortunately it was probably the worst possible side I could have indulged in: a nightshade veggie bomb comprising tomatoes, potatoes, eggplant and various kinds of peppers.

    Nightshade vegetables are notoriously toxic (despite mainstream claims that the toxins are neutralized by cooking), especially for those with a history of autoimmune disease, or leaky gut. They are also problematic for anyone with a history of allergic disorders or MCAS. It doesn’t help that traditional methods of picking and preparation that minimized the toxicity for otherwise healthy people are no longer followed.

    Pin on Hold the tomato
    Almost immediately after consuming this side dish I started to feel that first tickle in my throat and it was a slow downhill roll from there. Took 2-3 days, during which I had enough of a chance to head it off with some high dose vitamin C, but I’m one of those people who usually prefers to let nature take its course (maybe don’t do this in our current environment of repeated COVID infections, with all the problems they can bring).

    Once the illness got started I began to notice very clearly that what I ate had an almost immediate impact on how I felt. I think it probably required the sensitization of having been strictly carnivore for weeks beforehand.

    Thank you for reading Dr. Syed Haider. This post is public so feel free to share it.

    Share

    I could tell when I ate high histamine fruits or vegetables that my symptoms would worsen significantly, I might get an instant headache, stuffy nose, worsening cough, fatigue, dizziness, and even occasional anger outbursts that had plagued me before the carnivore experiment.

    All these can be due to histamine intolerance. When you’re sick or already exposed to something that lowers your histamine tolerance, adding histamine-containing foods or those that tend to liberate histamine is just added fuel for the fire.

    Histamine Intolerance Doctor Gilbert AZ
    Anyway this has been going around (not surprising since it is winter). Some people get bad diarrhea, for others it’s the cough that’s the worst.

    If you treat this early in the first day or two you can usually cut it short within the first week. If not then many people end up being somewhat under the weather for a couple weeks and the unlucky ones have lingering symptoms for many weeks. It’s not necessarily anything new, it happened before COVID too. Now people are hyperaware of it, and for good reason, because the current iterations are often due to the COVID bioweapon which damages every organ system.

    Whether or not COVID was diagnosed you can usually treat a cough heavy post viral syndrome with key lifestyle changes like avoiding airway irritants (eg use an air filter) low or even no carb (but first try a good quality medicinal honey 1-3 teaspoons dissolved in warm water 1-3 times a day), avoiding trigger foods, plenty of direct sunlight, good sleep; supplements from mygotostack.com like vitamin C, D, zinc, quercetin, turmeric, nigella sativa; and prescription meds from mygotodoc.com like: ivermectin and LDN (we can’t prescribe codeine for cough online since its a controlled substance).

    Other effective treatments include IV vitamin C, IV ozone, HBOT, or what’s easier and nearly as effective: a home oxygen concentrator a couple hours a day,

    However one of the best and most underappreciated ways to get rid of a lingering non productive (dry) cough is simple breathwork.

    That’s because it’s not always just a persistent infection or inflammation that leads to a persistent cough, it may be that, but it is also often a disordered breathing pattern that can develop after just a couple days of illness. This pattern becomes imprinted on the nervous system and can be hard to shake. The longer you leave it unaddressed the longer it may continue. The more you cough the more likely you are to keep coughing, and the less you cough the more likely you are to stop coughing.

    Now, when most people think of breathwork they think of deep breathing exercises. But deep breathing is usually a trigger for a coughing fit rather than any kind of solution (during my long COVID illness I also found it can also worsen anxiety).

    The real fix for a persistent cough (and anxiety) due to a disordered nervous system is often in breathing less, while becoming aware of the impending urge to cough and trying to head it off and suppress it.

    Practitioners of the Buteyko breathing method have a great exercise for stopping a persistent dry cough.

    Share

    When you feel the urge to cough you press your hand over your mouth, swallow and hold your breath for 5 seconds while telling yourself you don’t need to cough. Then start breathing slow and shallow through the nose, keeping your hand over your mouth. Imagine the air going in one nostril and out the other in a circle (obviously this is not actually happening it just helps keep the breathing light and not irritating to the throat, partly a psychological phenomenon).

    Do this whenever you feel the urge to cough during the day, and you’ll see that it often works rather well and makes you more aware of what triggers the coughing. Unless there is something more serious going on (don’t nocebo yourself, just assume there is not) it usually only takes 1-3 days of this to retrain your nervous system and end the cough for good.

    You can also check out other Buteyko and pranayama yoga breathing methods (like alternate nostril breathing) for stopping a cough on YouTube:


    If there is residual inflammation, often manifested by a post nasal drip irritating the throat leading to coughing fits (easy to test if you have this, just lie down flat and see if you start coughing, or get worse, within a minute or so), it’s also important to avoid trigger foods that raise histamine or lead your own body to release histamine.

    Some common ones include: the nightshades I mentioned (tomatoes, potatoes, eggplant, all peppers), bananas, strawberries, mangoes, citrus fruits, avocado, chocolate, dairy, preserved or canned meats and fish, leftover meat and fish, lentils, beans, alcohol, tea, coffee and there may be some that are individual specific (think of any foods that in small or large quantities have caused you problems in the past).

    If you don’t go low or no carb, then also avoid grains until better as they tend to be pro inflammatory.

    Fish oil supplements have a short term anti-inflammatory effect that may lead to a longer term proinflammatory outcome. I’m not clear on all the science and implications here, but you can check out Chris Masterjohn’s work on the topic. Generally speaking it seems to be fine to eat fatty fish for the Omega 3s, but most people should probably avoid the high dose supplementation currently recommended by some groups.

    Another key lifestyle measure that works great for the post nasal drip is lifting your head at night using 2-3 pillows (or a wedge pillow - also helps with chronic reflux), and even propping yourself up against the headboard or wall behind your bed. Might be uncomfortable at first, but it’s better than a night of hacking up your lungs.

    Manage Acid Reflux & more: EZsleep Wedge| EQUANIMO
    I’ve also used pieces of chewed and softened licorice root to help cover up the irritating sensation of a post nasal drip while sleeping.

    Using a neti pot a few times a day may also help with this, and you can add things like turmeric, hydrogen peroxide, iodine, or just go with the usual salt water flush.

    If there is a persistent infection then more drastic measures will be needed including the IV methods mentioned above, and you can consider nebulization of peroxide.

    Promising studies have been done on more exotic methods of relieving a cough such as nebulizing honey, drinking a mixture of honey and coffee syrup dissolved in water, and inhaling a very dilute mixture of capsaicin (from cayenne peppers - which can help with both cough and post nasal drop, and other than snorting or otherwise breathing it in, you can also mix it with honey or water and take it orally as an antihistamine).

    Finally, the most powerful herb I know of for insomnia and anxiety is the sedative-hypnotic mulungu bark, and it is also effective in treating various kinds of coughs.

    Let me know below if you’ve gotten sick this winter, and what you swear by to get better, especially what works for a prolonged dry nagging cough.

    https://blog.mygotodoc.com/p/destroying-super-immunity-and-getting

    https://telegra.ph/Destroying-Super-Immunity--Getting-Rid-of-That-Annoying-Cough-03-20
    Destroying Super Immunity & Getting Rid of That Annoying Cough Dr. Syed Haider I made it through multiple upper respiratory illnesses affecting my wife and kids over the last year without getting sick myself. The biggest difference maker seemed to be spending a lot of time outdoors in sunny Puerto Rico. It’s not just about the vitamin D that you get in the afternoons, it’s also about the lack of blue light toxicity you get the rest of the day from glass filtered indoor sunlight (or artificial lights). Blue light in the visible spectrum needs to be balanced by the naturally present infrared and UV spectrum in natural sunlight. Unfortunately both are blocked by typical window glass. Anyway, my long run of seemingly bulletproof immunity came to an inglorious end when I finally succumbed to what had been plaguing my nuclear family for a couple weeks: it began with a tickle in my throat, then progressed to a mild sore throat, stuffy and runny nose, bad a cough, and fatigue. It was rough going for a day or two. Hard to sleep with all the coughing. My post mortem analysis of what went wrong: I visited family overseas, where they live in an apartment full of artificial light and not much direct sun. I did my best to get outside, but couldnt do it anywhere near as much as I used to at home. Then (perhaps more or less important?) I started including once a week “stress test days” (nee cheat days) on my carnivore diet. That turned into a general laxity during my regular carnivore diet days, including eating out and being exposed to ubiquitous seed oils. Then one day I was enjoying my meat dish at a local restaurant and decided spur of the moment (always a mistake) to try the side dish I would have normally skipped. Unfortunately it was probably the worst possible side I could have indulged in: a nightshade veggie bomb comprising tomatoes, potatoes, eggplant and various kinds of peppers. Nightshade vegetables are notoriously toxic (despite mainstream claims that the toxins are neutralized by cooking), especially for those with a history of autoimmune disease, or leaky gut. They are also problematic for anyone with a history of allergic disorders or MCAS. It doesn’t help that traditional methods of picking and preparation that minimized the toxicity for otherwise healthy people are no longer followed. Pin on Hold the tomato Almost immediately after consuming this side dish I started to feel that first tickle in my throat and it was a slow downhill roll from there. Took 2-3 days, during which I had enough of a chance to head it off with some high dose vitamin C, but I’m one of those people who usually prefers to let nature take its course (maybe don’t do this in our current environment of repeated COVID infections, with all the problems they can bring). Once the illness got started I began to notice very clearly that what I ate had an almost immediate impact on how I felt. I think it probably required the sensitization of having been strictly carnivore for weeks beforehand. Thank you for reading Dr. Syed Haider. This post is public so feel free to share it. Share I could tell when I ate high histamine fruits or vegetables that my symptoms would worsen significantly, I might get an instant headache, stuffy nose, worsening cough, fatigue, dizziness, and even occasional anger outbursts that had plagued me before the carnivore experiment. All these can be due to histamine intolerance. When you’re sick or already exposed to something that lowers your histamine tolerance, adding histamine-containing foods or those that tend to liberate histamine is just added fuel for the fire. Histamine Intolerance Doctor Gilbert AZ Anyway this has been going around (not surprising since it is winter). Some people get bad diarrhea, for others it’s the cough that’s the worst. If you treat this early in the first day or two you can usually cut it short within the first week. If not then many people end up being somewhat under the weather for a couple weeks and the unlucky ones have lingering symptoms for many weeks. It’s not necessarily anything new, it happened before COVID too. Now people are hyperaware of it, and for good reason, because the current iterations are often due to the COVID bioweapon which damages every organ system. Whether or not COVID was diagnosed you can usually treat a cough heavy post viral syndrome with key lifestyle changes like avoiding airway irritants (eg use an air filter) low or even no carb (but first try a good quality medicinal honey 1-3 teaspoons dissolved in warm water 1-3 times a day), avoiding trigger foods, plenty of direct sunlight, good sleep; supplements from mygotostack.com like vitamin C, D, zinc, quercetin, turmeric, nigella sativa; and prescription meds from mygotodoc.com like: ivermectin and LDN (we can’t prescribe codeine for cough online since its a controlled substance). Other effective treatments include IV vitamin C, IV ozone, HBOT, or what’s easier and nearly as effective: a home oxygen concentrator a couple hours a day, However one of the best and most underappreciated ways to get rid of a lingering non productive (dry) cough is simple breathwork. That’s because it’s not always just a persistent infection or inflammation that leads to a persistent cough, it may be that, but it is also often a disordered breathing pattern that can develop after just a couple days of illness. This pattern becomes imprinted on the nervous system and can be hard to shake. The longer you leave it unaddressed the longer it may continue. The more you cough the more likely you are to keep coughing, and the less you cough the more likely you are to stop coughing. Now, when most people think of breathwork they think of deep breathing exercises. But deep breathing is usually a trigger for a coughing fit rather than any kind of solution (during my long COVID illness I also found it can also worsen anxiety). The real fix for a persistent cough (and anxiety) due to a disordered nervous system is often in breathing less, while becoming aware of the impending urge to cough and trying to head it off and suppress it. Practitioners of the Buteyko breathing method have a great exercise for stopping a persistent dry cough. Share When you feel the urge to cough you press your hand over your mouth, swallow and hold your breath for 5 seconds while telling yourself you don’t need to cough. Then start breathing slow and shallow through the nose, keeping your hand over your mouth. Imagine the air going in one nostril and out the other in a circle (obviously this is not actually happening it just helps keep the breathing light and not irritating to the throat, partly a psychological phenomenon). Do this whenever you feel the urge to cough during the day, and you’ll see that it often works rather well and makes you more aware of what triggers the coughing. Unless there is something more serious going on (don’t nocebo yourself, just assume there is not) it usually only takes 1-3 days of this to retrain your nervous system and end the cough for good. You can also check out other Buteyko and pranayama yoga breathing methods (like alternate nostril breathing) for stopping a cough on YouTube: If there is residual inflammation, often manifested by a post nasal drip irritating the throat leading to coughing fits (easy to test if you have this, just lie down flat and see if you start coughing, or get worse, within a minute or so), it’s also important to avoid trigger foods that raise histamine or lead your own body to release histamine. Some common ones include: the nightshades I mentioned (tomatoes, potatoes, eggplant, all peppers), bananas, strawberries, mangoes, citrus fruits, avocado, chocolate, dairy, preserved or canned meats and fish, leftover meat and fish, lentils, beans, alcohol, tea, coffee and there may be some that are individual specific (think of any foods that in small or large quantities have caused you problems in the past). If you don’t go low or no carb, then also avoid grains until better as they tend to be pro inflammatory. Fish oil supplements have a short term anti-inflammatory effect that may lead to a longer term proinflammatory outcome. I’m not clear on all the science and implications here, but you can check out Chris Masterjohn’s work on the topic. Generally speaking it seems to be fine to eat fatty fish for the Omega 3s, but most people should probably avoid the high dose supplementation currently recommended by some groups. Another key lifestyle measure that works great for the post nasal drip is lifting your head at night using 2-3 pillows (or a wedge pillow - also helps with chronic reflux), and even propping yourself up against the headboard or wall behind your bed. Might be uncomfortable at first, but it’s better than a night of hacking up your lungs. Manage Acid Reflux & more: EZsleep Wedge| EQUANIMO I’ve also used pieces of chewed and softened licorice root to help cover up the irritating sensation of a post nasal drip while sleeping. Using a neti pot a few times a day may also help with this, and you can add things like turmeric, hydrogen peroxide, iodine, or just go with the usual salt water flush. If there is a persistent infection then more drastic measures will be needed including the IV methods mentioned above, and you can consider nebulization of peroxide. Promising studies have been done on more exotic methods of relieving a cough such as nebulizing honey, drinking a mixture of honey and coffee syrup dissolved in water, and inhaling a very dilute mixture of capsaicin (from cayenne peppers - which can help with both cough and post nasal drop, and other than snorting or otherwise breathing it in, you can also mix it with honey or water and take it orally as an antihistamine). Finally, the most powerful herb I know of for insomnia and anxiety is the sedative-hypnotic mulungu bark, and it is also effective in treating various kinds of coughs. Let me know below if you’ve gotten sick this winter, and what you swear by to get better, especially what works for a prolonged dry nagging cough. https://blog.mygotodoc.com/p/destroying-super-immunity-and-getting 👉https://telegra.ph/Destroying-Super-Immunity--Getting-Rid-of-That-Annoying-Cough-03-20
    BLOG.MYGOTODOC.COM
    Destroying Super Immunity & Getting Rid of That Annoying Cough
    I made it through multiple upper respiratory illnesses affecting my wife and kids over the last year without getting sick myself. The biggest difference maker seemed to be spending a lot of time outdoors in sunny Puerto Rico. It’s not just about the vitamin D that you get in the afternoons, it’s also about the lack of blue light toxicity you get the rest of the day from glass filtered indoor sunlight (or artificial lights).
    1 Comments 0 Shares 21032 Views
  • What vitamins do you lack?

    If you often have bad breath, you lack vitamin B3.

    Even with mild bruises, bruises appear and do not go away for a long time - not enough vitamin C.

    Constipation can be caused by a deficiency of B vitamins.

    Dizziness and tinnitus - lack of vitamins B3 and E, as well as manganese and potassium.

    Redness of the eyes, inability to quickly adapt in the dark, barley - lack of vitamins A and B2.

    Dandruff appears - deficiency of vitamins B12, B6, F and selenium.

    Dark and brittle hair is a sign of a lack of vitamins B, F and iodine.

    Hair loss - lack of vitamins B9, C, H, inositol.

    Insomnia - a deficiency of B vitamins, potassium and calcium.

    Frequent nosebleeds - lack of vitamins C, K and B3.

    Acne and red spots on the neck are signs of vitamin A and B deficiency.

    Share with your loved ones

    Join us: t.me/Natural_Healing
    💋 What vitamins do you lack? ☘️ If you often have bad breath, you lack vitamin B3. ☘️ Even with mild bruises, bruises appear and do not go away for a long time - not enough vitamin C. ☘️Constipation can be caused by a deficiency of B vitamins. ☘️Dizziness and tinnitus - lack of vitamins B3 and E, as well as manganese and potassium. ☘️ Redness of the eyes, inability to quickly adapt in the dark, barley - lack of vitamins A and B2. ☘️ Dandruff appears - deficiency of vitamins B12, B6, F and selenium. ☘️ Dark and brittle hair is a sign of a lack of vitamins B, F and iodine. ☘️ Hair loss - lack of vitamins B9, C, H, inositol. ☘️ Insomnia - a deficiency of B vitamins, potassium and calcium. ☘️ Frequent nosebleeds - lack of vitamins C, K and B3. ☘️ Acne and red spots on the neck are signs of vitamin A and B deficiency. Share with your loved ones💞 Join us: t.me/Natural_Healing
    Like
    1
    0 Comments 0 Shares 2297 Views
  • CDC’s Own Scientists Found Masks Ineffective for Covid-19 but Recommended Them Anyway
    Officials at the Centers for Disease Control and Prevention openly questioned the findings of its own scientists’ studies contradicting the agency’s public messaging about mask effectiveness

    World Council for Health
    This article was originally published by The Defender — Children’s Health Defense’s News & Views Website.

    cdc masks ineffective covid feature
    The Centers for Disease Control and Prevention’s (CDC) own scientists conducted studies showing N95 respirators are no more effective at stopping viruses than surgical masks — yet the agency issued guidance contradicting those and other studies showing both types of masks are ineffective at stopping the spread of COVID-19, according to an investigation by independent journalist Paul D. Thacker.

    The investigation, published this week in two parts on The Disinformation Chronicle, details how CDC leadership openly questioned the findings of CDC scientists’ studies contradicting the agency’s public messaging about mask effectiveness.

    During the pandemic, mask advocates “shifted goalposts and demanded N95 respirators,” Thacker said, claiming they perform better than surgical masks at stopping the virus.

    If this content is important to you, share it!

    Share

    However, Thacker said CDC scientists found no difference between N95 and surgical masks in the ability to stop the spread of respiratory viruses. The findings of the CDC studies are consistent with other peer-reviewed studies on the efficacy of masks in preventing COVID-19, according to Thacker.

    “But the CDC responded by saying people can’t say that,” Thacker told The Defender.

    To shut down the controversy, the CDC, in its Jan. 23 post on preventing the transmission of pathogens in healthcare settings, warned researchers that to suggest facemasks and respirators are the same “is not scientifically correct,” Thacker wrote.

    CDC ignores own studies questioning N95, mask effectiveness

    According to Thacker, CDC guidance for controlling the spread of infections had not been updated since 2007. This prompted the CDC, in 2022, to select “a bunch of science experts,” and ask them “to update the agency’s scientific guidance to hospitals on how to control infections.”

    In November 2023, the experts produced an 80-page systematic review and meta-analysis, examining whether N95 respirators were more effective than surgical masks. The review found that while N95 respirators are better at filtering particles, the finding that they are more effective at stopping viruses “has been less conclusive.”

    The systematic review also examined the “effectiveness” of N95 respirators and surgical masks “under ‘real world’” conditions and found “no difference” between the two.

    The review also found numerous symptoms reported by N95 mask users, including: “difficulty breathing, headaches, and dizziness; skin barrier damage and itching; fatigue; and difficulty talking.”

    According to Thacker, the CDC is not pleased with these findings, suggesting in its recent update that its own scientists were wrong.

    “Although masks can provide some level of filtration, the level of filtration is not comparable to NIOSH Approved respirators,” the CDC said.

    The post also stated, “The COVID-19 pandemic has forever changed the approach we take in healthcare settings to protect healthcare personnel, patients, and others from transmission of respiratory infections.”

    More evidence contradicting the CDC’s public position came at a June 2023 CDC meeting in Atlanta, when Erin Stone, MPH, a public health analyst in the agency’s Office of Guidelines and Evidence Review, presented the findings of a meta-analysis on the effectiveness of N95 respirators and surgical masks.

    According to Stone, the data “suggests no difference” in their effectiveness.

    Yet, in November 2023 testimony before the U.S. House of Representatives’ Energy and Commerce Committee, CDC Director Mandy Cohen sidestepped questions regarding mask effectiveness and refused to deny she would reinstate mask mandates for children.

    According to Thacker, in December 2023, just six days after Cohen’s testimony, The BMJ’s Archives of Disease in Childhood journal published a study finding that “mask recommendations for children are not supported by scientific evidence.”

    “Recommending child masking does not meet the accepted practice of promulgating only medical interventions where benefits clearly outweigh harms,” the study authors noted.

    Thacker: CDC guidance based on politics, not science

    Thacker said the CDC contradicted its own findings on mask efficacy even in the early stages of the COVID-19 pandemic.

    “Soon after the pandemic started, the CDC began promoting masks to stop the spread of COVID,” Thacker wrote. “And it did so despite CDC publishing a May 2020 policy study in their own journal, ‘Emerging Infectious Diseases,’ that did not find a ‘substantial effect’ for masks in stopping the transmission of respiratory viruses.”


    twitter.com/CDCgov/status/1378462317109731334
    That same month, the CDC began publicly promoting N95 respirators as a more effective means of controlling the spread of COVID-19.

    However, on its webpage promoting the superiority of N95 respirators, the CDC admitted “there’s not a whole lot of evidence that N95 respirators do in fact work better than masks at stopping viruses,” Thacker wrote.

    “Laboratory studies have demonstrated that FFRs [filtering facepiece respirators] provide greater protection against aerosols compared with surgical masks … however, the results of clinical studies have been inconclusive,” the CDC wrote, citing a 2019 study in JAMA comparing N95 respirators to masks.

    “Among outpatient health care personnel, N95 respirators vs medical masks as worn by participants in this trial resulted in no significant difference in the incidence of laboratory-confirmed influenza,” the JAMA study noted.


    twitter.com/CDCgov/status/1256655451195715585
    According to Thacker, the results of these studies confirm the widely accepted pre-COVID-19 scientific consensus on the ineffectiveness of masks of any kind in stopping the spread of viruses. Thacker cited statements the World Health Organization made in 2019 and the CDC’s guidance on virus control.

    In a 2020 appearance on CBS’ “60 Minutes,” Dr. Anthony Fauci said that while a mask might “block a droplet” and “make people feel a little better,” it does not provide “the perfect protection that people think it is.”



    According to Thacker, “For some reason, a ‘masks work’ political movement began to grow,” despite Fauci’s statements and the findings of these studies.

    “I’m not really sure what happened or what we do next,” Thacker wrote. “But something weird took place in America where liberal elites began messaging among themselves ‘masks work.’ They then grew this into a crusade.”

    The movement was effective in getting the CDC on board with issuing mask guidance, Thacker said.

    Four years after the onset of the pandemic, the CDC now openly cheerleads for masks, despite research the agency published showing that masks don’t really protect people from catching viruses, he said.

    “And this is why the experts advising the CDC are getting all this pushback: they didn’t tell the CDC what the CDC wanted to hear,” Thacker wrote.

    Harvey Risch, M.D., Ph.D., professor emeritus and senior research scientist in epidemiology (chronic diseases) at the Yale School of Public Health, told The Disinformation Chronicle the CDC “has succumbed to political influences.”

    Risch said:

    “It made policies for school closures in order to please the teachers’ union. Its charitable organization allows pharma to feed it hundreds of millions of dollars that would be illegal to go directly to the agency, and this gives pharma major influence on CDC policies.”

    According to Thacker, the CDC has continued to double down on guidance promoting mask efficacy. A Jan. 23 letter the agency sent to its own advisers appears to encourage them to add more mask guidance to the agency’s new guidelines for the spread of pathogens, based on the conclusion that N95 respirators are effective.

    “Too much science is forcing CDC to request a science do over,” Thacker wrote, referring to the CDC’s Jan. 23 post, which states that its new recommendations should not “be misread to suggest equivalency between facemasks and NIOSH Approved respirators, which is not scientifically correct nor the intent of the draft language.”

    Thacker said his investigation shows that “in their guidance to the CDC, experts do recommend masks as part of what they call ‘transmission-based guidance’ which the CDC defines as a second tier of infection control.” However, the CDC’s own guidance also finds that masks are effective only for “source control” — preventing an already infected person from infecting others.

    “But this isn’t what the CDC wants,” Thacker wrote. “They want the experts to write guidelines that recommend healthy people wear masks, even though research shows masks won’t really stop healthy people from getting sick.”

    “The CDC has caught the ‘masks work’ political wave and is now demanding that independent experts conform to their preferred mask dictates,” he added.

    In doing so, the CDC is rejecting science it doesn’t like, including several other non-CDC studies that have questioned mask effectiveness.

    A study published in Annals of Internal Medicine in November 2022 found no difference between N95 respirators and surgical masks in stopping the spread of COVID-19. These findings were mirrored in a January 2023 Cochrane meta-analysis on mask effectiveness.

    According to the Cochrane report, “The use of a N95/P2 respirators compared to medical/surgical masks probably makes little or no difference for the objective and more precise outcome of laboratory‐confirmed influenza infection.”

    A May 2023 study published in Ecotoxicology and Environmental Safety suggests N95 respirators may expose wearers to dangerous levels of toxic compounds linked to seizures and cancer.

    A September 2023 meta-analysis published in Clinical Research Study examined mask studies published since 2019 in the CDC’s Morbidity and Mortality Weekly Report (MMWR).

    According to the findings of the meta-analysis:

    “MMWR publications pertaining to masks drew positive conclusions about mask effectiveness >75% of the time despite only 30% testing masks and <15% having statistically significant results. No studies were randomized, yet over half drew causal conclusions.

    “The level of evidence generated was low and the conclusions were most often unsupported by the data. Our findings raise concern about the reliability of the journal for informing health policy.”

    Real-world examples also call into question narratives regarding mask efficacy.

    Sweden, for instance, did not mandate or recommend masks for the general public during the first wave of the COVID-19 pandemic, and only did so in certain situations in the later stages of the pandemic, according to The Conversation. Yet, its total excess deaths during the first two years of the pandemic were among the lowest in Europe.”

    In 2020, Swedish state epidemiologist Anders Tegnell said, “We see no point in wearing a face mask in Sweden, not even on public transport,” adding there were “at least three heavyweight reports … which all state that the scientific evidence is weak.”

    A Swedish government commission noted low levels of excess mortality in 2020 and 2021 and said that, at most, masks should have been “recommended.”

    Soon after the report was released, a Feb. 25, 2022, Boston Herald op-ed stated that Sweden “got it right.”

    “I don’t understand what is driving the ‘masks work’ political movement,” Thacker told The Defender. “There were plenty of stories written pointing out that there isn’t much scientific evidence that masks stop respiratory virus spread.”

    “Maybe people were just scared and wanted to believe masks provide protection?” he said.

    Thacker also cited the historical precedent of the Spanish Flu epidemic in 1918, when the Red Cross campaigned for masks all across America.

    “California’s state board of health ran a study comparing towns that had mask mandates against those that did not. They found that there was no difference and published the study in the American Journal of Public Health in 1920,” Thacker said.

    “Maybe these mask campaigners need to read a little history,” he added.

    Thacker is now calling on whistleblowers inside the CDC to contact him “to discuss what is going on inside the agency.”

    “I’m talking to CDC people and hope to learn what is going on inside the agency. I plan to write more on this,” Thacker told The Defender.

    “CDC Director Mandy Cohen wants to restore trust in the agency, but that won’t happen if she keeps putting politics ahead of scientific evidence,” he said.

    If this content is important to you, share it with your network!

    Share

    This article was written by Michael Nevradakis, Ph.D. and originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.


    If you find value in this Substack and have the means, please consider making a contribution to support the World Council for Health. Thank you.

    Upgrade to Paid Subscription

    Refer a friend

    Donate Subscriptions

    Give Direct to WCH

    https://worldcouncilforhealth.substack.com/p/cdcs-own-scientists-found-masks-ineffective

    https://donshafi911.blogspot.com/2024/02/cdcs-own-scientists-found-masks_16.html
    CDC’s Own Scientists Found Masks Ineffective for Covid-19 but Recommended Them Anyway Officials at the Centers for Disease Control and Prevention openly questioned the findings of its own scientists’ studies contradicting the agency’s public messaging about mask effectiveness World Council for Health This article was originally published by The Defender — Children’s Health Defense’s News & Views Website. cdc masks ineffective covid feature The Centers for Disease Control and Prevention’s (CDC) own scientists conducted studies showing N95 respirators are no more effective at stopping viruses than surgical masks — yet the agency issued guidance contradicting those and other studies showing both types of masks are ineffective at stopping the spread of COVID-19, according to an investigation by independent journalist Paul D. Thacker. The investigation, published this week in two parts on The Disinformation Chronicle, details how CDC leadership openly questioned the findings of CDC scientists’ studies contradicting the agency’s public messaging about mask effectiveness. During the pandemic, mask advocates “shifted goalposts and demanded N95 respirators,” Thacker said, claiming they perform better than surgical masks at stopping the virus. If this content is important to you, share it! Share However, Thacker said CDC scientists found no difference between N95 and surgical masks in the ability to stop the spread of respiratory viruses. The findings of the CDC studies are consistent with other peer-reviewed studies on the efficacy of masks in preventing COVID-19, according to Thacker. “But the CDC responded by saying people can’t say that,” Thacker told The Defender. To shut down the controversy, the CDC, in its Jan. 23 post on preventing the transmission of pathogens in healthcare settings, warned researchers that to suggest facemasks and respirators are the same “is not scientifically correct,” Thacker wrote. CDC ignores own studies questioning N95, mask effectiveness According to Thacker, CDC guidance for controlling the spread of infections had not been updated since 2007. This prompted the CDC, in 2022, to select “a bunch of science experts,” and ask them “to update the agency’s scientific guidance to hospitals on how to control infections.” In November 2023, the experts produced an 80-page systematic review and meta-analysis, examining whether N95 respirators were more effective than surgical masks. The review found that while N95 respirators are better at filtering particles, the finding that they are more effective at stopping viruses “has been less conclusive.” The systematic review also examined the “effectiveness” of N95 respirators and surgical masks “under ‘real world’” conditions and found “no difference” between the two. The review also found numerous symptoms reported by N95 mask users, including: “difficulty breathing, headaches, and dizziness; skin barrier damage and itching; fatigue; and difficulty talking.” According to Thacker, the CDC is not pleased with these findings, suggesting in its recent update that its own scientists were wrong. “Although masks can provide some level of filtration, the level of filtration is not comparable to NIOSH Approved respirators,” the CDC said. The post also stated, “The COVID-19 pandemic has forever changed the approach we take in healthcare settings to protect healthcare personnel, patients, and others from transmission of respiratory infections.” More evidence contradicting the CDC’s public position came at a June 2023 CDC meeting in Atlanta, when Erin Stone, MPH, a public health analyst in the agency’s Office of Guidelines and Evidence Review, presented the findings of a meta-analysis on the effectiveness of N95 respirators and surgical masks. According to Stone, the data “suggests no difference” in their effectiveness. Yet, in November 2023 testimony before the U.S. House of Representatives’ Energy and Commerce Committee, CDC Director Mandy Cohen sidestepped questions regarding mask effectiveness and refused to deny she would reinstate mask mandates for children. According to Thacker, in December 2023, just six days after Cohen’s testimony, The BMJ’s Archives of Disease in Childhood journal published a study finding that “mask recommendations for children are not supported by scientific evidence.” “Recommending child masking does not meet the accepted practice of promulgating only medical interventions where benefits clearly outweigh harms,” the study authors noted. Thacker: CDC guidance based on politics, not science Thacker said the CDC contradicted its own findings on mask efficacy even in the early stages of the COVID-19 pandemic. “Soon after the pandemic started, the CDC began promoting masks to stop the spread of COVID,” Thacker wrote. “And it did so despite CDC publishing a May 2020 policy study in their own journal, ‘Emerging Infectious Diseases,’ that did not find a ‘substantial effect’ for masks in stopping the transmission of respiratory viruses.” twitter.com/CDCgov/status/1378462317109731334 That same month, the CDC began publicly promoting N95 respirators as a more effective means of controlling the spread of COVID-19. However, on its webpage promoting the superiority of N95 respirators, the CDC admitted “there’s not a whole lot of evidence that N95 respirators do in fact work better than masks at stopping viruses,” Thacker wrote. “Laboratory studies have demonstrated that FFRs [filtering facepiece respirators] provide greater protection against aerosols compared with surgical masks … however, the results of clinical studies have been inconclusive,” the CDC wrote, citing a 2019 study in JAMA comparing N95 respirators to masks. “Among outpatient health care personnel, N95 respirators vs medical masks as worn by participants in this trial resulted in no significant difference in the incidence of laboratory-confirmed influenza,” the JAMA study noted. twitter.com/CDCgov/status/1256655451195715585 According to Thacker, the results of these studies confirm the widely accepted pre-COVID-19 scientific consensus on the ineffectiveness of masks of any kind in stopping the spread of viruses. Thacker cited statements the World Health Organization made in 2019 and the CDC’s guidance on virus control. In a 2020 appearance on CBS’ “60 Minutes,” Dr. Anthony Fauci said that while a mask might “block a droplet” and “make people feel a little better,” it does not provide “the perfect protection that people think it is.” According to Thacker, “For some reason, a ‘masks work’ political movement began to grow,” despite Fauci’s statements and the findings of these studies. “I’m not really sure what happened or what we do next,” Thacker wrote. “But something weird took place in America where liberal elites began messaging among themselves ‘masks work.’ They then grew this into a crusade.” The movement was effective in getting the CDC on board with issuing mask guidance, Thacker said. Four years after the onset of the pandemic, the CDC now openly cheerleads for masks, despite research the agency published showing that masks don’t really protect people from catching viruses, he said. “And this is why the experts advising the CDC are getting all this pushback: they didn’t tell the CDC what the CDC wanted to hear,” Thacker wrote. Harvey Risch, M.D., Ph.D., professor emeritus and senior research scientist in epidemiology (chronic diseases) at the Yale School of Public Health, told The Disinformation Chronicle the CDC “has succumbed to political influences.” Risch said: “It made policies for school closures in order to please the teachers’ union. Its charitable organization allows pharma to feed it hundreds of millions of dollars that would be illegal to go directly to the agency, and this gives pharma major influence on CDC policies.” According to Thacker, the CDC has continued to double down on guidance promoting mask efficacy. A Jan. 23 letter the agency sent to its own advisers appears to encourage them to add more mask guidance to the agency’s new guidelines for the spread of pathogens, based on the conclusion that N95 respirators are effective. “Too much science is forcing CDC to request a science do over,” Thacker wrote, referring to the CDC’s Jan. 23 post, which states that its new recommendations should not “be misread to suggest equivalency between facemasks and NIOSH Approved respirators, which is not scientifically correct nor the intent of the draft language.” Thacker said his investigation shows that “in their guidance to the CDC, experts do recommend masks as part of what they call ‘transmission-based guidance’ which the CDC defines as a second tier of infection control.” However, the CDC’s own guidance also finds that masks are effective only for “source control” — preventing an already infected person from infecting others. “But this isn’t what the CDC wants,” Thacker wrote. “They want the experts to write guidelines that recommend healthy people wear masks, even though research shows masks won’t really stop healthy people from getting sick.” “The CDC has caught the ‘masks work’ political wave and is now demanding that independent experts conform to their preferred mask dictates,” he added. In doing so, the CDC is rejecting science it doesn’t like, including several other non-CDC studies that have questioned mask effectiveness. A study published in Annals of Internal Medicine in November 2022 found no difference between N95 respirators and surgical masks in stopping the spread of COVID-19. These findings were mirrored in a January 2023 Cochrane meta-analysis on mask effectiveness. According to the Cochrane report, “The use of a N95/P2 respirators compared to medical/surgical masks probably makes little or no difference for the objective and more precise outcome of laboratory‐confirmed influenza infection.” A May 2023 study published in Ecotoxicology and Environmental Safety suggests N95 respirators may expose wearers to dangerous levels of toxic compounds linked to seizures and cancer. A September 2023 meta-analysis published in Clinical Research Study examined mask studies published since 2019 in the CDC’s Morbidity and Mortality Weekly Report (MMWR). According to the findings of the meta-analysis: “MMWR publications pertaining to masks drew positive conclusions about mask effectiveness >75% of the time despite only 30% testing masks and <15% having statistically significant results. No studies were randomized, yet over half drew causal conclusions. “The level of evidence generated was low and the conclusions were most often unsupported by the data. Our findings raise concern about the reliability of the journal for informing health policy.” Real-world examples also call into question narratives regarding mask efficacy. Sweden, for instance, did not mandate or recommend masks for the general public during the first wave of the COVID-19 pandemic, and only did so in certain situations in the later stages of the pandemic, according to The Conversation. Yet, its total excess deaths during the first two years of the pandemic were among the lowest in Europe.” In 2020, Swedish state epidemiologist Anders Tegnell said, “We see no point in wearing a face mask in Sweden, not even on public transport,” adding there were “at least three heavyweight reports … which all state that the scientific evidence is weak.” A Swedish government commission noted low levels of excess mortality in 2020 and 2021 and said that, at most, masks should have been “recommended.” Soon after the report was released, a Feb. 25, 2022, Boston Herald op-ed stated that Sweden “got it right.” “I don’t understand what is driving the ‘masks work’ political movement,” Thacker told The Defender. “There were plenty of stories written pointing out that there isn’t much scientific evidence that masks stop respiratory virus spread.” “Maybe people were just scared and wanted to believe masks provide protection?” he said. Thacker also cited the historical precedent of the Spanish Flu epidemic in 1918, when the Red Cross campaigned for masks all across America. “California’s state board of health ran a study comparing towns that had mask mandates against those that did not. They found that there was no difference and published the study in the American Journal of Public Health in 1920,” Thacker said. “Maybe these mask campaigners need to read a little history,” he added. Thacker is now calling on whistleblowers inside the CDC to contact him “to discuss what is going on inside the agency.” “I’m talking to CDC people and hope to learn what is going on inside the agency. I plan to write more on this,” Thacker told The Defender. “CDC Director Mandy Cohen wants to restore trust in the agency, but that won’t happen if she keeps putting politics ahead of scientific evidence,” he said. If this content is important to you, share it with your network! Share This article was written by Michael Nevradakis, Ph.D. and originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense. If you find value in this Substack and have the means, please consider making a contribution to support the World Council for Health. Thank you. Upgrade to Paid Subscription Refer a friend Donate Subscriptions Give Direct to WCH https://worldcouncilforhealth.substack.com/p/cdcs-own-scientists-found-masks-ineffective https://donshafi911.blogspot.com/2024/02/cdcs-own-scientists-found-masks_16.html
    WORLDCOUNCILFORHEALTH.SUBSTACK.COM
    CDC’s Own Scientists Found Masks Ineffective for Covid-19 but Recommended Them Anyway
    Officials at the Centers for Disease Control and Prevention openly questioned the findings of its own scientists’ studies contradicting the agency’s public messaging about mask effectiveness
    0 Comments 0 Shares 23056 Views
  • CDC'S own scientists conducted studies showing N95 respirators are no more effective at stopping viruses than surgical masks — yet the agency issued guidance contradicting those and other studies showing both types of masks are ineffective at stopping the spread of COVID-19, according to an investigation by Paul D. Thacker.


    CDC’s Own Scientists Found Masks Ineffective for COVID — But Agency Recommended Them Anyway
    According to an investigation by independent journalist Paul D. Thacker published this week in The Disinformation Chronicle, officials at the Centers for Disease Control and Prevention openly questioned the findings of its own scientists’ studies contradicting the agency’s public messaging about mask effectiveness

    Michael Nevradakis, Ph.D.
    cdc masks ineffective covid feature
    Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free.

    The Centers for Disease Control and Prevention’s (CDC) own scientists conducted studies showing N95 respirators are no more effective at stopping viruses than surgical masks — yet the agency issued guidance contradicting those and other studies showing both types of masks are ineffective at stopping the spread of COVID-19, according to an investigation by independent journalist Paul D. Thacker.

    The investigation, published this week in two parts on The Disinformation Chronicle, details how CDC leadership openly questioned the findings of CDC scientists’ studies contradicting the agency’s public messaging about mask effectiveness.

    During the pandemic, mask advocates “shifted goalposts and demanded N95 respirators,” Thacker said, claiming they perform better than surgical masks at stopping the virus.

    However, Thacker said CDC scientists found no difference between N95 and surgical masks in the ability to stop the spread of respiratory viruses. The findings of the CDC studies are consistent with other peer-reviewed studies on the efficacy of masks in preventing COVID-19, according to Thacker.

    “But the CDC responded by saying people can’t say that,” Thacker told The Defender.

    To shut down the controversy, the CDC, in its Jan. 23 post on preventing the transmission of pathogens in healthcare settings, warned researchers that to suggest facemasks and respirators are the same “is not scientifically correct,” Thacker wrote.

    CDC ignores own studies questioning N95, mask effectiveness

    According to Thacker, CDC guidance for controlling the spread of infections had not been updated since 2007. This prompted the CDC, in 2022, to select “a bunch of science experts,” and ask them “to update the agency’s scientific guidance to hospitals on how to control infections.”

    In November 2023, the experts produced an 80-page systematic review and meta-analysis, examining whether N95 respirators were more effective than surgical masks. The review found that while N95 respirators are better at filtering particles, the finding that they are more effective at stopping viruses “has been less conclusive.”

    The systematic review also examined the “effectiveness” of N95 respirators and surgical masks “under ‘real world’” conditions and found “no difference” between the two.

    The review also found numerous symptoms reported by N95 mask users, including: “difficulty breathing, headaches, and dizziness; skin barrier damage and itching; fatigue; and difficulty talking.”

    According to Thacker, the CDC is not pleased with these findings, suggesting in its recent update that its own scientists were wrong.

    “Although masks can provide some level of filtration, the level of filtration is not comparable to NIOSH Approved respirators,” the CDC said.

    The post also stated, “The COVID-19 pandemic has forever changed the approach we take in healthcare settings to protect healthcare personnel, patients, and others from transmission of respiratory infections.”

    More evidence contradicting the CDC’s public position came at a June 2023 CDC meeting in Atlanta, when Erin Stone, MPH, a public health analyst in the agency’s Office of Guidelines and Evidence Review, presented the findings of a meta-analysis on the effectiveness of N95 respirators and surgical masks.

    RFK Jr. and Brian Hooker Vax-Unvax
    RFK Jr. and Brian Hooker’s New Book: “Vax-Unvax”

    Order Now

    According to Stone, the data “suggests no difference” in their effectiveness.

    Yet, in November 2023 testimony before the U.S. House of Representatives’ Energy and Commerce Committee, CDC Director Mandy Cohen sidestepped questions regarding mask effectiveness and refused to deny she would reinstate mask mandates for children.

    According to Thacker, in December 2023, just six days after Cohen’s testimony, The BMJ’s Archives of Disease in Childhood journal published a study finding that “mask recommendations for children are not supported by scientific evidence.”

    “Recommending child masking does not meet the accepted practice of promulgating only medical interventions where benefits clearly outweigh harms,” the study authors noted.

    Thacker: CDC guidance based on politics, not science

    Thacker said the CDC contradicted its own findings on mask efficacy even in the early stages of the COVID-19 pandemic.

    “Soon after the pandemic started, the CDC began promoting masks to stop the spread of COVID,” Thacker wrote. “And it did so despite CDC publishing a May 2020 policy study in their own journal, ‘Emerging Infectious Diseases,’ that did not find a ‘substantial effect’ for masks in stopping the transmission of respiratory viruses.”


    That same month, the CDC began publicly promoting N95 respirators as a more effective means of controlling the spread of COVID-19.

    However, on its webpage promoting the superiority of N95 respirators, the CDC admitted “there’s not a whole lot of evidence that N95 respirators do in fact work better than masks at stopping viruses,” Thacker wrote.

    “Laboratory studies have demonstrated that FFRs [filtering facepiece respirators] provide greater protection against aerosols compared with surgical masks … however, the results of clinical studies have been inconclusive,” the CDC wrote, citing a 2019 study in JAMA comparing N95 respirators to masks.

    “Among outpatient health care personnel, N95 respirators vs medical masks as worn by participants in this trial resulted in no significant difference in the incidence of laboratory-confirmed influenza,” the JAMA study noted.


    According to Thacker, the results of these studies confirm the widely accepted pre-COVID-19 scientific consensus on the ineffectiveness of masks of any kind in stopping the spread of viruses. Thacker cited statements the World Health Organization made in 2019 and the CDC’s guidance on virus control.

    In a 2020 appearance on CBS’ “60 Minutes,” Dr. Anthony Fauci said that while a mask might “block a droplet” and “make people feel a little better,” it does not provide “the perfect protection that people think it is.”



    According to Thacker, “For some reason, a ‘masks work’ political movement began to grow,” despite Fauci’s statements and the findings of these studies.

    “I’m not really sure what happened or what we do next,” Thacker wrote. “But something weird took place in America where liberal elites began messaging among themselves ‘masks work.’ They then grew this into a crusade.”

    The movement was effective in getting the CDC on board with issuing mask guidance, Thacker said.

    Four years after the onset of the pandemic, the CDC now openly cheerleads for masks, despite research the agency published showing that masks don’t really protect people from catching viruses, he said.

    “And this is why the experts advising the CDC are getting all this pushback: they didn’t tell the CDC what the CDC wanted to hear,” Thacker wrote.

    Harvey Risch, M.D., Ph.D., professor emeritus and senior research scientist in epidemiology (chronic diseases) at the Yale School of Public Health, told The Disinformation Chronicle the CDC “has succumbed to political influences.”

    Risch said:

    “It made policies for school closures in order to please the teachers’ union. Its charitable organization allows pharma to feed it hundreds of millions of dollars that would be illegal to go directly to the agency, and this gives pharma major influence on CDC policies.”

    According to Thacker, the CDC has continued to double down on guidance promoting mask efficacy. A Jan. 23 letter the agency sent to its own advisers appears to encourage them to add more mask guidance to the agency’s new guidelines for the spread of pathogens, based on the conclusion that N95 respirators are effective.

    “Too much science is forcing CDC to request a science do over,” Thacker wrote, referring to the CDC’s Jan. 23 post, which states that its new recommendations should not “be misread to suggest equivalency between facemasks and NIOSH Approved respirators, which is not scientifically correct nor the intent of the draft language.”

    Thacker said his investigation shows that “in their guidance to the CDC, experts do recommend masks as part of what they call ‘transmission-based guidance’ which the CDC defines as a second tier of infection control.” However, the CDC’s own guidance also finds that masks are effective only for “source control” — preventing an already infected person from infecting others.

    “But this isn’t what the CDC wants,” Thacker wrote. “They want the experts to write guidelines that recommend healthy people wear masks, even though research shows masks won’t really stop healthy people from getting sick.”

    “The CDC has caught the ‘masks work’ political wave and is now demanding that independent experts conform to their preferred mask dictates,” he added.

    In doing so, the CDC is rejecting science it doesn’t like, including several other non-CDC studies that have questioned mask effectiveness.

    A study published in Annals of Internal Medicine in November 2022 found no difference between N95 respirators and surgical masks in stopping the spread of COVID-19. These findings were mirrored in a January 2023 Cochrane meta-analysis on mask effectiveness.

    According to the Cochrane report, “The use of a N95/P2 respirators compared to medical/surgical masks probably makes little or no difference for the objective and more precise outcome of laboratory‐confirmed influenza infection.”

    A May 2023 study published in Ecotoxicology and Environmental Safety suggests N95 respirators may expose wearers to dangerous levels of toxic compounds linked to seizures and cancer.

    A September 2023 meta-analysis published in Clinical Research Study examined mask studies published since 2019 in the CDC’s Morbidity and Mortality Weekly Report (MMWR).

    According to the findings of the meta-analysis:

    “MMWR publications pertaining to masks drew positive conclusions about mask effectiveness >75% of the time despite only 30% testing masks and <15% having statistically significant results. No studies were randomized, yet over half drew causal conclusions.

    “The level of evidence generated was low and the conclusions were most often unsupported by the data. Our findings raise concern about the reliability of the journal for informing health policy.”

    Real-world examples also call into question narratives regarding mask efficacy.

    Sweden, for instance, did not mandate or recommend masks for the general public during the first wave of the COVID-19 pandemic, and only did so in certain situations in the later stages of the pandemic, according to The Conversation. Yet, its total excess deaths during the first two years of the pandemic were among the lowest in Europe.”

    In 2020, Swedish state epidemiologist Anders Tegnell said, “We see no point in wearing a face mask in Sweden, not even on public transport,” adding there were “at least three heavyweight reports … which all state that the scientific evidence is weak.”

    A Swedish government commission noted low levels of excess mortality in 2020 and 2021 and said that, at most, masks should have been “recommended.”

    Soon after the report was released, a Feb. 25, 2022, Boston Herald op-ed stated that Sweden “got it right.”

    “I don’t understand what is driving the ‘masks work’ political movement,” Thacker told The Defender. “There were plenty of stories written pointing out that there isn’t much scientific evidence that masks stop respiratory virus spread.”

    “Maybe people were just scared and wanted to believe masks provide protection?” he said.

    Thacker also cited the historical precedent of the Spanish Flu epidemic in 1918, when the Red Cross campaigned for masks all across America.

    “California’s state board of health ran a study comparing towns that had mask mandates against those that did not. They found that there was no difference and published the study in the American Journal of Public Health in 1920,” Thacker said.

    “Maybe these mask campaigners need to read a little history,” he added.

    Thacker is now calling on whistleblowers inside the CDC to contact him “to discuss what is going on inside the agency.”

    “I’m talking to CDC people and hope to learn what is going on inside the agency. I plan to write more on this,” Thacker told The Defender.

    “CDC Director Mandy Cohen wants to restore trust in the agency, but that won’t happen if she keeps putting politics ahead of scientific evidence,” he said.

    DETAILS
    https://childrenshealthdefense.org/defender/cdc-scientists-masks-ineffective-covid-agency-recommended/

    Join @ShankaraChetty


    https://donshafi911.blogspot.com/2024/02/cdcs-own-scientists-found-masks.html
    CDC'S own scientists conducted studies showing N95 respirators are no more effective at stopping viruses than surgical masks — yet the agency issued guidance contradicting those and other studies showing both types of masks are ineffective at stopping the spread of COVID-19, according to an investigation by Paul D. Thacker. CDC’s Own Scientists Found Masks Ineffective for COVID — But Agency Recommended Them Anyway According to an investigation by independent journalist Paul D. Thacker published this week in The Disinformation Chronicle, officials at the Centers for Disease Control and Prevention openly questioned the findings of its own scientists’ studies contradicting the agency’s public messaging about mask effectiveness Michael Nevradakis, Ph.D. cdc masks ineffective covid feature Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free. The Centers for Disease Control and Prevention’s (CDC) own scientists conducted studies showing N95 respirators are no more effective at stopping viruses than surgical masks — yet the agency issued guidance contradicting those and other studies showing both types of masks are ineffective at stopping the spread of COVID-19, according to an investigation by independent journalist Paul D. Thacker. The investigation, published this week in two parts on The Disinformation Chronicle, details how CDC leadership openly questioned the findings of CDC scientists’ studies contradicting the agency’s public messaging about mask effectiveness. During the pandemic, mask advocates “shifted goalposts and demanded N95 respirators,” Thacker said, claiming they perform better than surgical masks at stopping the virus. However, Thacker said CDC scientists found no difference between N95 and surgical masks in the ability to stop the spread of respiratory viruses. The findings of the CDC studies are consistent with other peer-reviewed studies on the efficacy of masks in preventing COVID-19, according to Thacker. “But the CDC responded by saying people can’t say that,” Thacker told The Defender. To shut down the controversy, the CDC, in its Jan. 23 post on preventing the transmission of pathogens in healthcare settings, warned researchers that to suggest facemasks and respirators are the same “is not scientifically correct,” Thacker wrote. CDC ignores own studies questioning N95, mask effectiveness According to Thacker, CDC guidance for controlling the spread of infections had not been updated since 2007. This prompted the CDC, in 2022, to select “a bunch of science experts,” and ask them “to update the agency’s scientific guidance to hospitals on how to control infections.” In November 2023, the experts produced an 80-page systematic review and meta-analysis, examining whether N95 respirators were more effective than surgical masks. The review found that while N95 respirators are better at filtering particles, the finding that they are more effective at stopping viruses “has been less conclusive.” The systematic review also examined the “effectiveness” of N95 respirators and surgical masks “under ‘real world’” conditions and found “no difference” between the two. The review also found numerous symptoms reported by N95 mask users, including: “difficulty breathing, headaches, and dizziness; skin barrier damage and itching; fatigue; and difficulty talking.” According to Thacker, the CDC is not pleased with these findings, suggesting in its recent update that its own scientists were wrong. “Although masks can provide some level of filtration, the level of filtration is not comparable to NIOSH Approved respirators,” the CDC said. The post also stated, “The COVID-19 pandemic has forever changed the approach we take in healthcare settings to protect healthcare personnel, patients, and others from transmission of respiratory infections.” More evidence contradicting the CDC’s public position came at a June 2023 CDC meeting in Atlanta, when Erin Stone, MPH, a public health analyst in the agency’s Office of Guidelines and Evidence Review, presented the findings of a meta-analysis on the effectiveness of N95 respirators and surgical masks. RFK Jr. and Brian Hooker Vax-Unvax RFK Jr. and Brian Hooker’s New Book: “Vax-Unvax” Order Now According to Stone, the data “suggests no difference” in their effectiveness. Yet, in November 2023 testimony before the U.S. House of Representatives’ Energy and Commerce Committee, CDC Director Mandy Cohen sidestepped questions regarding mask effectiveness and refused to deny she would reinstate mask mandates for children. According to Thacker, in December 2023, just six days after Cohen’s testimony, The BMJ’s Archives of Disease in Childhood journal published a study finding that “mask recommendations for children are not supported by scientific evidence.” “Recommending child masking does not meet the accepted practice of promulgating only medical interventions where benefits clearly outweigh harms,” the study authors noted. Thacker: CDC guidance based on politics, not science Thacker said the CDC contradicted its own findings on mask efficacy even in the early stages of the COVID-19 pandemic. “Soon after the pandemic started, the CDC began promoting masks to stop the spread of COVID,” Thacker wrote. “And it did so despite CDC publishing a May 2020 policy study in their own journal, ‘Emerging Infectious Diseases,’ that did not find a ‘substantial effect’ for masks in stopping the transmission of respiratory viruses.” That same month, the CDC began publicly promoting N95 respirators as a more effective means of controlling the spread of COVID-19. However, on its webpage promoting the superiority of N95 respirators, the CDC admitted “there’s not a whole lot of evidence that N95 respirators do in fact work better than masks at stopping viruses,” Thacker wrote. “Laboratory studies have demonstrated that FFRs [filtering facepiece respirators] provide greater protection against aerosols compared with surgical masks … however, the results of clinical studies have been inconclusive,” the CDC wrote, citing a 2019 study in JAMA comparing N95 respirators to masks. “Among outpatient health care personnel, N95 respirators vs medical masks as worn by participants in this trial resulted in no significant difference in the incidence of laboratory-confirmed influenza,” the JAMA study noted. According to Thacker, the results of these studies confirm the widely accepted pre-COVID-19 scientific consensus on the ineffectiveness of masks of any kind in stopping the spread of viruses. Thacker cited statements the World Health Organization made in 2019 and the CDC’s guidance on virus control. In a 2020 appearance on CBS’ “60 Minutes,” Dr. Anthony Fauci said that while a mask might “block a droplet” and “make people feel a little better,” it does not provide “the perfect protection that people think it is.” According to Thacker, “For some reason, a ‘masks work’ political movement began to grow,” despite Fauci’s statements and the findings of these studies. “I’m not really sure what happened or what we do next,” Thacker wrote. “But something weird took place in America where liberal elites began messaging among themselves ‘masks work.’ They then grew this into a crusade.” The movement was effective in getting the CDC on board with issuing mask guidance, Thacker said. Four years after the onset of the pandemic, the CDC now openly cheerleads for masks, despite research the agency published showing that masks don’t really protect people from catching viruses, he said. “And this is why the experts advising the CDC are getting all this pushback: they didn’t tell the CDC what the CDC wanted to hear,” Thacker wrote. Harvey Risch, M.D., Ph.D., professor emeritus and senior research scientist in epidemiology (chronic diseases) at the Yale School of Public Health, told The Disinformation Chronicle the CDC “has succumbed to political influences.” Risch said: “It made policies for school closures in order to please the teachers’ union. Its charitable organization allows pharma to feed it hundreds of millions of dollars that would be illegal to go directly to the agency, and this gives pharma major influence on CDC policies.” According to Thacker, the CDC has continued to double down on guidance promoting mask efficacy. A Jan. 23 letter the agency sent to its own advisers appears to encourage them to add more mask guidance to the agency’s new guidelines for the spread of pathogens, based on the conclusion that N95 respirators are effective. “Too much science is forcing CDC to request a science do over,” Thacker wrote, referring to the CDC’s Jan. 23 post, which states that its new recommendations should not “be misread to suggest equivalency between facemasks and NIOSH Approved respirators, which is not scientifically correct nor the intent of the draft language.” Thacker said his investigation shows that “in their guidance to the CDC, experts do recommend masks as part of what they call ‘transmission-based guidance’ which the CDC defines as a second tier of infection control.” However, the CDC’s own guidance also finds that masks are effective only for “source control” — preventing an already infected person from infecting others. “But this isn’t what the CDC wants,” Thacker wrote. “They want the experts to write guidelines that recommend healthy people wear masks, even though research shows masks won’t really stop healthy people from getting sick.” “The CDC has caught the ‘masks work’ political wave and is now demanding that independent experts conform to their preferred mask dictates,” he added. In doing so, the CDC is rejecting science it doesn’t like, including several other non-CDC studies that have questioned mask effectiveness. A study published in Annals of Internal Medicine in November 2022 found no difference between N95 respirators and surgical masks in stopping the spread of COVID-19. These findings were mirrored in a January 2023 Cochrane meta-analysis on mask effectiveness. According to the Cochrane report, “The use of a N95/P2 respirators compared to medical/surgical masks probably makes little or no difference for the objective and more precise outcome of laboratory‐confirmed influenza infection.” A May 2023 study published in Ecotoxicology and Environmental Safety suggests N95 respirators may expose wearers to dangerous levels of toxic compounds linked to seizures and cancer. A September 2023 meta-analysis published in Clinical Research Study examined mask studies published since 2019 in the CDC’s Morbidity and Mortality Weekly Report (MMWR). According to the findings of the meta-analysis: “MMWR publications pertaining to masks drew positive conclusions about mask effectiveness >75% of the time despite only 30% testing masks and <15% having statistically significant results. No studies were randomized, yet over half drew causal conclusions. “The level of evidence generated was low and the conclusions were most often unsupported by the data. Our findings raise concern about the reliability of the journal for informing health policy.” Real-world examples also call into question narratives regarding mask efficacy. Sweden, for instance, did not mandate or recommend masks for the general public during the first wave of the COVID-19 pandemic, and only did so in certain situations in the later stages of the pandemic, according to The Conversation. Yet, its total excess deaths during the first two years of the pandemic were among the lowest in Europe.” In 2020, Swedish state epidemiologist Anders Tegnell said, “We see no point in wearing a face mask in Sweden, not even on public transport,” adding there were “at least three heavyweight reports … which all state that the scientific evidence is weak.” A Swedish government commission noted low levels of excess mortality in 2020 and 2021 and said that, at most, masks should have been “recommended.” Soon after the report was released, a Feb. 25, 2022, Boston Herald op-ed stated that Sweden “got it right.” “I don’t understand what is driving the ‘masks work’ political movement,” Thacker told The Defender. “There were plenty of stories written pointing out that there isn’t much scientific evidence that masks stop respiratory virus spread.” “Maybe people were just scared and wanted to believe masks provide protection?” he said. Thacker also cited the historical precedent of the Spanish Flu epidemic in 1918, when the Red Cross campaigned for masks all across America. “California’s state board of health ran a study comparing towns that had mask mandates against those that did not. They found that there was no difference and published the study in the American Journal of Public Health in 1920,” Thacker said. “Maybe these mask campaigners need to read a little history,” he added. Thacker is now calling on whistleblowers inside the CDC to contact him “to discuss what is going on inside the agency.” “I’m talking to CDC people and hope to learn what is going on inside the agency. I plan to write more on this,” Thacker told The Defender. “CDC Director Mandy Cohen wants to restore trust in the agency, but that won’t happen if she keeps putting politics ahead of scientific evidence,” he said. DETAILS ⬇️ https://childrenshealthdefense.org/defender/cdc-scientists-masks-ineffective-covid-agency-recommended/ Join ➡️ @ShankaraChetty https://donshafi911.blogspot.com/2024/02/cdcs-own-scientists-found-masks.html
    CHILDRENSHEALTHDEFENSE.ORG
    CDC’s Own Scientists Found Masks Ineffective for COVID — But Agency Recommended Them Anyway
    According to an investigation by independent journalist Paul D. Thacker published this week in The Disinformation Chronicle, officials at the Centers for Disease Control and Prevention openly questioned the findings of its own scientists’ studies contradicting the agency’s public messaging about mask effectiveness
    Angry
    1
    0 Comments 1 Shares 18128 Views
  • The Truth About HPV Vaccination, Part 2: Studies Link the Vaccines to Neurological, Autoimmune Disorders
    Researchers who looked closely into the Gardasil HPV vaccine concluded the risks from the vaccine seem to significantly outweigh the as-yet-unproven long-term benefits.

    The Epoch Times

    Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free.

    By Dr. Yuhong Dong

    Editor’s Note: This second installment in a multi-part series about the human papillomavirus, or HPV, vaccine examines studies that link the vaccines to increased risk of serious neurological and autoimmune disorders. Read Part 1 here.

    Summary of key facts

    A Danish review of 79,102 female and 16,568 male subjects, found human papillomavirus (HPV) vaccines had significantly increased rates of serious nervous system disorders. Postural orthostatic tachycardia syndrome (POTS) and complex regional pain syndrome were judged “definitely associated” with the HPV vaccine.
    A large Danish and Swedish study including nearly 300,000 girls found a significant association between the HPV vaccine and increased rates of Bechet’s syndrome (rate ratio 3.37), Raynaud’s disease (1.67) and type 1 diabetes (1.29).
    A large study including 3 million Danish and Swedish women aged 18 to 44, identified seven adverse events with statistically significant increased risks following HPV vaccination: Hashimoto’s thyroiditis, celiac disease, lupus erythematosus, pemphigus vulgaris, Addison’s disease, Raynaud’s disease and encephalitis, myelitis, or encephalomyelitis.
    A 2017 French study of over 2.2 million young girls found evidence of a 3.78-fold increased risk of Guillain-Barré syndrome (GBS). A 2011 U.S. study found nearly a two-and-a-half to 10 times greater risk of acquiring GBS within six weeks post-Gardasil vaccination.
    While the underlying mechanisms causing these autoimmune reactions are not yet fully understood, some researchers speculate that the sizable overlap in protein sequences between the HPV and the human genome may cause the immune system to attack itself. Others are concerned that the adjuvants (such as aluminum) used to attract the attention of the immune system may be causing harm.
    Neurological and autoimmune disorders

    Danish review found increased nervous system disorder

    In 2020, a group of Danish scientists conducted a systematic review of the overall benefits and harms of HPV vaccines.

    Twenty-four eligible randomized controlled clinical studies were obtained, with a total of 95,670 participants, mostly women, and 49 months mean weighted follow-up.

    Almost all controls were given an active comparator vaccine (typically a hepatitis vaccine with a comparable aluminum-based adjuvant).

    Given that the adjuvant is highly immunogenic by design (it is meant to grab the attention of the immune system), this trial design makes it difficult to detect an excess risk with the HPV vaccines.

    Without true controls (such as a saline placebo), the real risks of HPV vaccination cannot be accurately assessed.

    In the vaccine group, 367 cancers were detected, compared to 490 in the comparator group.

    Younger participants (15 to 29) seemed to benefit more from the vaccine concerning preventing moderate HPV-related intraepithelial neoplasia compared to older participants (ages 21 to 72). Younger participants also had fewer fatal harms.

    Even though the studies were flawed in their design, at four years post-vaccination, those who had received the HPV vaccines had significantly increased rates of serious nervous system disorders: 49%, as well as general harms totaling 7%.

    The serious harms that were judged “definitely associated” with HPV vaccines were postural orthostatic tachycardia syndrome and complex regional pain syndrome. POTS had a nearly twofold increase in the vaccinated group.

    By July 2017, only two-thirds of the results from HPV vaccine trials had been published, and only about half the results had been posted, due to manuscript length limitations, reporting bias and confounding journal articles offering a limited view of trial outcomes.

    This Danish systematic review compiled data from all the HPV trials to offer a summary of the evidence thus far.

    Nevertheless, the investigators acknowledged that despite three years of work, the limitations of their analysis remained. These included reporting bias, incomplete reporting, data fragmentation and limited trial follow-up.

    These investigators similarly note that the trials were powered to assess the benefits of HPV vaccination, not rare harms. The degree to which benefits outweigh risks is therefore unknown.

    They concluded that future research should carefully evaluate the harms following Gardasil 9 compared to Gardasil because the former contains more than double the virus proteins and aluminum-containing adjuvant than the same dose of Gardasil.

    RFK Jr. and Brian Hooker Vax-Unvax
    RFK Jr. and Brian Hooker’s New Book: “Vax-Unvax”

    Order Now

    Large studies reveal autoimmune events

    In 2009, the HPV4 vaccine was integrated into the Danish childhood vaccination program. Since then, two large cohort studies on the HPV4 vaccine adverse events have been carried out using the hospital-based healthcare registries of Denmark and Sweden.

    The first study in Denmark and Sweden included 296,826 girls aged 10 to 17 who received a total of 696,420 HPV4 vaccine doses.

    The scientists evaluated rate ratios for autoimmune events and found no significant association for 20 out of 23 events.

    They found a significant association between the HPV4 vaccine and Bechet’s syndrome (rate ratio 3.37), Raynaud’s disease (1.67) and type 1 diabetes (1.29).

    But after further review, they concluded that there was insufficient evidence for a causal association, because of the weakness of the signal and the lack of an underlying mechanism to explain biological plausibility.

    In a second large cohort study, the same team expanded their research to more than 3 million Danish and Swedish adult women aged 18 to 44.

    The authors identified seven adverse events with statistically significant increased risks following HPV4 vaccination: Hashimoto’s thyroiditis, celiac disease, lupus erythematosus, pemphigus vulgaris, Addison’s disease, Raynaud’s disease and encephalitis, myelitis or encephalomyelitis.

    After sensitivity analyses, the association between HPV4 vaccination and celiac disease was the most robust finding.

    Celiac disease is a condition where a person’s immune system attacks the body’s own gut after eating gluten.

    As the graph below shows, the scientists used two risk periods after HPV4 vaccination: the first 180 days and after.

    1 time since first dose HPV4 vaccine coeliac cases
    Time since the first dose of the HPV4 vaccine for vaccinated coeliac cases in a cohort of Danish and Swedish women. Credit: Journal of Internal Medicine
    The authors noted that the observed 56% increased risk of celiac disease “was strong, and the increase was strikingly similar in both risk periods after vaccination.”

    Celiac disease is underdiagnosed in Denmark.

    So one possible explanation is that vaccination visits allow a chance for this and other conditions to be diagnosed and explored.

    This explanation suggests that the association between the HPV vaccine and autoimmune disorders may be coincidental.

    However, given the lack of any real control groups in these studies, as well as the growing body of scientific literature from countries around the world showing problems with the HPV vaccine, dismissing these safety signals as coincidence seems short-sighted.

    Large French study and U.S. VAERS study identify risks of Guillain-Barré Syndrome

    The concern about autoimmune disease adverse events has contributed to low HPV vaccination uptake in France.

    A 2017 study of over 2.2 million young girls in France found troubling evidence of a link with Guillain-Barré syndrome. GBS is a condition that arises when our own antibodies attack the nerves.

    The incidence of GBS was found to be 1.4 per 100,000 person-years among the vaccinated girls compared to 0.4 per 100,000 among the unvaccinated, resulting in an increased risk of GBS of more than 200%.

    The association appeared to be “particularly marked in the first months following vaccination.”

    This finding is corroborated by the pattern of adverse reactions reported worldwide. Data from a large number of case reports document similar serious adverse events associated with Gardasil administration, with nervous system disorders of autoimmune origin being the most frequently reported.

    A 2011 U.S. study found that the estimated weekly reporting rate of post-Gardasil GBS within the first six weeks (6.6 per 10,000,000) was higher than in the general population, and higher than post-Menactra and post-influenza vaccinations.

    In particular, there was nearly a two-and-a-half to 10 times greater risk of acquiring GBS within six weeks after vaccination, compared to the general population.

    Additionally, the study found Gardasil vaccination was associated with approximately eight-and-a-half times more emergency department visits, 12.5 times more hospitalizations, 10 times more life-threatening events and 26.5 times more disability than the Menactra vaccination.

    Plausible mechanisms of harm

    Despite the conflicting data in the scientific literature to date, it is clear that the HPV vaccines can cause autoimmune disorders in susceptible people. But how?

    Autoimmunity has been reported as a complication of natural infection as well as virus vaccination. This phenomenon has been observed with many viruses, including the Epstein-Barr virus, COVID-19 and HPV.

    According to a 2019 study, the HPV vaccine contains epitopes — portions of the virus proteins — that overlap with the human proteins.

    This means that if we develop antibodies to those viruses, we may also generate autoantibodies to our own cells, which is the root cause of autoimmune dysfunction.

    The study showed that most of the immunoreactive HPV L1 epi­topes are overlapping peptides present in human proteins.

    The authors explained that this “unexpected enormous size of the peptide overlap between the HPV epitopes and human proteins” is relevant, and may be why a wide variety of autoimmune diseases have been reported post-HPV vaccination, including ovarian failure, systemic lupus erythematosus, breast cancer and sudden death, among others.

    Why some people develop these conditions and others do not is unclear.

    The authors suggest that vaccines should target the few peptides that do not overlap with human proteins, but which do overlap with the other HPVs.

    Despite this overlap and the potential for causing autoimmune disease, medical doctors usually ignore or dismiss the connection. We are told that these diseases are rare.

    The human body has something called immune tolerance. This protects a person’s immune system against attacking itself. Therefore, HPV infection is also “immune tolerated,” which means it lays dormant for some time until it becomes cancerous.

    HPV vaccination was actually designed with this immune tolerance in mind.

    Given the human body’s built-in defenses against autoimmune conditions, vaccinology requires an immunogenic catalyst to get the body’s attention. This is the job of an adjuvant.

    An adjuvant is an ingredient used in a vaccine that the body recognizes as foreign. It is added to vaccines so that the body will mount a stronger immune response.

    The idea is that in attacking the adjuvant, the body will also recognize other vaccine ingredients (in this case, purified HPV proteins).

    In addition, the antigen dose is much higher than in natural infections and the capsids in the vaccine are directly exposed to systemic immune responses as opposed to the virus staying relatively hidden within the natural barrier of the skin following infection.

    The vaccine was well-designed to trigger an immune response, but this advantage may come at a cost: Generating antibodies to HPV proteins through vaccination could, theoretically, set the stage for an autoimmune attack.

    Link between HPV-vaccine-associated nervous system dysfunction and autoimmunity

    A December 2022 Danish and German study was designed to elucidate a possible mechanism of harm.

    The lead author, Dr. Jesper Mehlsen, a specialist in treating autoimmune conditions, noted that the HPV major capsid L1s antigen resembles human autonomic nerve receptors, including G-protein coupled receptors (GPCR).

    According to the researchers, in the past several years, case series of suspected vaccination side effects have pointed to three disease entities: POTS, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and complex regional pain syndrome. These syndromes may be associated with neuroendocrine GPCR antibodies.

    From 2011 to 2018, researchers saw 845 patients (839 females, six males) with suspected side effects following the HPV4 vaccine. The control group included vaccinated people without side effects.

    Moderate to severe fatigue was recorded in 83.3% of the patients but in none of the controls.

    A high prevalence of symptoms, such as dizziness (91%), heart palpitations (71%), nausea (80%) and hyperactive bladder suggested that the patients were experiencing some kind of autonomic dysfunction.

    Autonomic dysfunction occurs when the part of the nervous system that controls well-being and balance does not function properly.

    2 most frequent symptoms hpv vaccine
    Most frequent symptoms reported by 612 patients in Denmark. Credit: Journal of Autoimmunity
    Twenty-four percent higher antinuclear antibodies (ANA, a common type of autoantibodies) were found in patients, suggesting possible autoimmunity.

    3 antinuclear antibodies HPV vaccines
    A larger proportion of the symptomatic patients were found with a common type of autoantibodies compared to healthy controls. Credit: Journal of Autoimmunity
    Antibodies against the adrenergic ß-2-receptor and muscarinic M-2 receptors were also found significantly higher in patients.

    Many of the symptoms, including immune activation and autonomic dysregulation, could be mediated or aggravated by dysregulated autoantibodies against adrenergic receptors and impaired peripheral adrenergic function.

    The authors suggested that girls and women with probable side effects of HPV vaccination have symptoms and biological markers compatible with an autoimmune disease closely resembling that seen in ME/CFS.

    Interestingly, people who already had HPV infections at some point appeared to be at greater risk for adverse events following vaccination.

    The authors noted that “prior disease may precondition some individuals for vaccine-related adverse events.”

    They also noted that some of the adverse events resembled long-COVID symptoms.

    Universal HPV vaccination called into question

    Academic researcher at the University of British Columbia, Lucija Tomljenovic, and neuroscientist Christopher Shaw, who have closely looked into Gardasil, have argued that the risks from the vaccine seem to significantly outweigh the as-yet-unproven long-term benefits.

    In a 2012 comment published in the American Journal of Public Health, they took issue with “incomplete and inaccurate” data and poorly designed trials.

    Vaccination is unjustified if the vaccine carries any substantial risk, as healthy teenagers face little to no risk of dying from cervical cancer.

    Risk-benefit analyses must be conducted to ascertain the overall balance of benefits and harms on both individual and societal levels.

    Reprinted with permission from The Epoch Times. Dr. Yuhong Dong, a medical doctor who also holds a doctorate in infectious diseases in China, is the chief scientific officer and co-founder of a Swiss biotech company and former senior medical scientific expert for antiviral drug development at Novartis Pharma in Switzerland.

    If you or your child suffered harm after receiving the Gardasil HPV vaccine, you may have a legal claim. Please visit Wisner Baum for a free case evaluation. Click here to watch a Gardasil litigation update interview with Wisner Baum Senior Partner Bijan Esfandiari.

    The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of Children's Health Defense.

    https://childrenshealthdefense.org/defender/truth-hpv-vaccine-part-2-et/

    https://donshafi911.blogspot.com/2024/01/the-truth-about-hpv-vaccination-part-2.html
    The Truth About HPV Vaccination, Part 2: Studies Link the Vaccines to Neurological, Autoimmune Disorders Researchers who looked closely into the Gardasil HPV vaccine concluded the risks from the vaccine seem to significantly outweigh the as-yet-unproven long-term benefits. The Epoch Times Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free. By Dr. Yuhong Dong Editor’s Note: This second installment in a multi-part series about the human papillomavirus, or HPV, vaccine examines studies that link the vaccines to increased risk of serious neurological and autoimmune disorders. Read Part 1 here. Summary of key facts A Danish review of 79,102 female and 16,568 male subjects, found human papillomavirus (HPV) vaccines had significantly increased rates of serious nervous system disorders. Postural orthostatic tachycardia syndrome (POTS) and complex regional pain syndrome were judged “definitely associated” with the HPV vaccine. A large Danish and Swedish study including nearly 300,000 girls found a significant association between the HPV vaccine and increased rates of Bechet’s syndrome (rate ratio 3.37), Raynaud’s disease (1.67) and type 1 diabetes (1.29). A large study including 3 million Danish and Swedish women aged 18 to 44, identified seven adverse events with statistically significant increased risks following HPV vaccination: Hashimoto’s thyroiditis, celiac disease, lupus erythematosus, pemphigus vulgaris, Addison’s disease, Raynaud’s disease and encephalitis, myelitis, or encephalomyelitis. A 2017 French study of over 2.2 million young girls found evidence of a 3.78-fold increased risk of Guillain-Barré syndrome (GBS). A 2011 U.S. study found nearly a two-and-a-half to 10 times greater risk of acquiring GBS within six weeks post-Gardasil vaccination. While the underlying mechanisms causing these autoimmune reactions are not yet fully understood, some researchers speculate that the sizable overlap in protein sequences between the HPV and the human genome may cause the immune system to attack itself. Others are concerned that the adjuvants (such as aluminum) used to attract the attention of the immune system may be causing harm. Neurological and autoimmune disorders Danish review found increased nervous system disorder In 2020, a group of Danish scientists conducted a systematic review of the overall benefits and harms of HPV vaccines. Twenty-four eligible randomized controlled clinical studies were obtained, with a total of 95,670 participants, mostly women, and 49 months mean weighted follow-up. Almost all controls were given an active comparator vaccine (typically a hepatitis vaccine with a comparable aluminum-based adjuvant). Given that the adjuvant is highly immunogenic by design (it is meant to grab the attention of the immune system), this trial design makes it difficult to detect an excess risk with the HPV vaccines. Without true controls (such as a saline placebo), the real risks of HPV vaccination cannot be accurately assessed. In the vaccine group, 367 cancers were detected, compared to 490 in the comparator group. Younger participants (15 to 29) seemed to benefit more from the vaccine concerning preventing moderate HPV-related intraepithelial neoplasia compared to older participants (ages 21 to 72). Younger participants also had fewer fatal harms. Even though the studies were flawed in their design, at four years post-vaccination, those who had received the HPV vaccines had significantly increased rates of serious nervous system disorders: 49%, as well as general harms totaling 7%. The serious harms that were judged “definitely associated” with HPV vaccines were postural orthostatic tachycardia syndrome and complex regional pain syndrome. POTS had a nearly twofold increase in the vaccinated group. By July 2017, only two-thirds of the results from HPV vaccine trials had been published, and only about half the results had been posted, due to manuscript length limitations, reporting bias and confounding journal articles offering a limited view of trial outcomes. This Danish systematic review compiled data from all the HPV trials to offer a summary of the evidence thus far. Nevertheless, the investigators acknowledged that despite three years of work, the limitations of their analysis remained. These included reporting bias, incomplete reporting, data fragmentation and limited trial follow-up. These investigators similarly note that the trials were powered to assess the benefits of HPV vaccination, not rare harms. The degree to which benefits outweigh risks is therefore unknown. They concluded that future research should carefully evaluate the harms following Gardasil 9 compared to Gardasil because the former contains more than double the virus proteins and aluminum-containing adjuvant than the same dose of Gardasil. RFK Jr. and Brian Hooker Vax-Unvax RFK Jr. and Brian Hooker’s New Book: “Vax-Unvax” Order Now Large studies reveal autoimmune events In 2009, the HPV4 vaccine was integrated into the Danish childhood vaccination program. Since then, two large cohort studies on the HPV4 vaccine adverse events have been carried out using the hospital-based healthcare registries of Denmark and Sweden. The first study in Denmark and Sweden included 296,826 girls aged 10 to 17 who received a total of 696,420 HPV4 vaccine doses. The scientists evaluated rate ratios for autoimmune events and found no significant association for 20 out of 23 events. They found a significant association between the HPV4 vaccine and Bechet’s syndrome (rate ratio 3.37), Raynaud’s disease (1.67) and type 1 diabetes (1.29). But after further review, they concluded that there was insufficient evidence for a causal association, because of the weakness of the signal and the lack of an underlying mechanism to explain biological plausibility. In a second large cohort study, the same team expanded their research to more than 3 million Danish and Swedish adult women aged 18 to 44. The authors identified seven adverse events with statistically significant increased risks following HPV4 vaccination: Hashimoto’s thyroiditis, celiac disease, lupus erythematosus, pemphigus vulgaris, Addison’s disease, Raynaud’s disease and encephalitis, myelitis or encephalomyelitis. After sensitivity analyses, the association between HPV4 vaccination and celiac disease was the most robust finding. Celiac disease is a condition where a person’s immune system attacks the body’s own gut after eating gluten. As the graph below shows, the scientists used two risk periods after HPV4 vaccination: the first 180 days and after. 1 time since first dose HPV4 vaccine coeliac cases Time since the first dose of the HPV4 vaccine for vaccinated coeliac cases in a cohort of Danish and Swedish women. Credit: Journal of Internal Medicine The authors noted that the observed 56% increased risk of celiac disease “was strong, and the increase was strikingly similar in both risk periods after vaccination.” Celiac disease is underdiagnosed in Denmark. So one possible explanation is that vaccination visits allow a chance for this and other conditions to be diagnosed and explored. This explanation suggests that the association between the HPV vaccine and autoimmune disorders may be coincidental. However, given the lack of any real control groups in these studies, as well as the growing body of scientific literature from countries around the world showing problems with the HPV vaccine, dismissing these safety signals as coincidence seems short-sighted. Large French study and U.S. VAERS study identify risks of Guillain-Barré Syndrome The concern about autoimmune disease adverse events has contributed to low HPV vaccination uptake in France. A 2017 study of over 2.2 million young girls in France found troubling evidence of a link with Guillain-Barré syndrome. GBS is a condition that arises when our own antibodies attack the nerves. The incidence of GBS was found to be 1.4 per 100,000 person-years among the vaccinated girls compared to 0.4 per 100,000 among the unvaccinated, resulting in an increased risk of GBS of more than 200%. The association appeared to be “particularly marked in the first months following vaccination.” This finding is corroborated by the pattern of adverse reactions reported worldwide. Data from a large number of case reports document similar serious adverse events associated with Gardasil administration, with nervous system disorders of autoimmune origin being the most frequently reported. A 2011 U.S. study found that the estimated weekly reporting rate of post-Gardasil GBS within the first six weeks (6.6 per 10,000,000) was higher than in the general population, and higher than post-Menactra and post-influenza vaccinations. In particular, there was nearly a two-and-a-half to 10 times greater risk of acquiring GBS within six weeks after vaccination, compared to the general population. Additionally, the study found Gardasil vaccination was associated with approximately eight-and-a-half times more emergency department visits, 12.5 times more hospitalizations, 10 times more life-threatening events and 26.5 times more disability than the Menactra vaccination. Plausible mechanisms of harm Despite the conflicting data in the scientific literature to date, it is clear that the HPV vaccines can cause autoimmune disorders in susceptible people. But how? Autoimmunity has been reported as a complication of natural infection as well as virus vaccination. This phenomenon has been observed with many viruses, including the Epstein-Barr virus, COVID-19 and HPV. According to a 2019 study, the HPV vaccine contains epitopes — portions of the virus proteins — that overlap with the human proteins. This means that if we develop antibodies to those viruses, we may also generate autoantibodies to our own cells, which is the root cause of autoimmune dysfunction. The study showed that most of the immunoreactive HPV L1 epi­topes are overlapping peptides present in human proteins. The authors explained that this “unexpected enormous size of the peptide overlap between the HPV epitopes and human proteins” is relevant, and may be why a wide variety of autoimmune diseases have been reported post-HPV vaccination, including ovarian failure, systemic lupus erythematosus, breast cancer and sudden death, among others. Why some people develop these conditions and others do not is unclear. The authors suggest that vaccines should target the few peptides that do not overlap with human proteins, but which do overlap with the other HPVs. Despite this overlap and the potential for causing autoimmune disease, medical doctors usually ignore or dismiss the connection. We are told that these diseases are rare. The human body has something called immune tolerance. This protects a person’s immune system against attacking itself. Therefore, HPV infection is also “immune tolerated,” which means it lays dormant for some time until it becomes cancerous. HPV vaccination was actually designed with this immune tolerance in mind. Given the human body’s built-in defenses against autoimmune conditions, vaccinology requires an immunogenic catalyst to get the body’s attention. This is the job of an adjuvant. An adjuvant is an ingredient used in a vaccine that the body recognizes as foreign. It is added to vaccines so that the body will mount a stronger immune response. The idea is that in attacking the adjuvant, the body will also recognize other vaccine ingredients (in this case, purified HPV proteins). In addition, the antigen dose is much higher than in natural infections and the capsids in the vaccine are directly exposed to systemic immune responses as opposed to the virus staying relatively hidden within the natural barrier of the skin following infection. The vaccine was well-designed to trigger an immune response, but this advantage may come at a cost: Generating antibodies to HPV proteins through vaccination could, theoretically, set the stage for an autoimmune attack. Link between HPV-vaccine-associated nervous system dysfunction and autoimmunity A December 2022 Danish and German study was designed to elucidate a possible mechanism of harm. The lead author, Dr. Jesper Mehlsen, a specialist in treating autoimmune conditions, noted that the HPV major capsid L1s antigen resembles human autonomic nerve receptors, including G-protein coupled receptors (GPCR). According to the researchers, in the past several years, case series of suspected vaccination side effects have pointed to three disease entities: POTS, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and complex regional pain syndrome. These syndromes may be associated with neuroendocrine GPCR antibodies. From 2011 to 2018, researchers saw 845 patients (839 females, six males) with suspected side effects following the HPV4 vaccine. The control group included vaccinated people without side effects. Moderate to severe fatigue was recorded in 83.3% of the patients but in none of the controls. A high prevalence of symptoms, such as dizziness (91%), heart palpitations (71%), nausea (80%) and hyperactive bladder suggested that the patients were experiencing some kind of autonomic dysfunction. Autonomic dysfunction occurs when the part of the nervous system that controls well-being and balance does not function properly. 2 most frequent symptoms hpv vaccine Most frequent symptoms reported by 612 patients in Denmark. Credit: Journal of Autoimmunity Twenty-four percent higher antinuclear antibodies (ANA, a common type of autoantibodies) were found in patients, suggesting possible autoimmunity. 3 antinuclear antibodies HPV vaccines A larger proportion of the symptomatic patients were found with a common type of autoantibodies compared to healthy controls. Credit: Journal of Autoimmunity Antibodies against the adrenergic ß-2-receptor and muscarinic M-2 receptors were also found significantly higher in patients. Many of the symptoms, including immune activation and autonomic dysregulation, could be mediated or aggravated by dysregulated autoantibodies against adrenergic receptors and impaired peripheral adrenergic function. The authors suggested that girls and women with probable side effects of HPV vaccination have symptoms and biological markers compatible with an autoimmune disease closely resembling that seen in ME/CFS. Interestingly, people who already had HPV infections at some point appeared to be at greater risk for adverse events following vaccination. The authors noted that “prior disease may precondition some individuals for vaccine-related adverse events.” They also noted that some of the adverse events resembled long-COVID symptoms. Universal HPV vaccination called into question Academic researcher at the University of British Columbia, Lucija Tomljenovic, and neuroscientist Christopher Shaw, who have closely looked into Gardasil, have argued that the risks from the vaccine seem to significantly outweigh the as-yet-unproven long-term benefits. In a 2012 comment published in the American Journal of Public Health, they took issue with “incomplete and inaccurate” data and poorly designed trials. Vaccination is unjustified if the vaccine carries any substantial risk, as healthy teenagers face little to no risk of dying from cervical cancer. Risk-benefit analyses must be conducted to ascertain the overall balance of benefits and harms on both individual and societal levels. Reprinted with permission from The Epoch Times. Dr. Yuhong Dong, a medical doctor who also holds a doctorate in infectious diseases in China, is the chief scientific officer and co-founder of a Swiss biotech company and former senior medical scientific expert for antiviral drug development at Novartis Pharma in Switzerland. If you or your child suffered harm after receiving the Gardasil HPV vaccine, you may have a legal claim. Please visit Wisner Baum for a free case evaluation. Click here to watch a Gardasil litigation update interview with Wisner Baum Senior Partner Bijan Esfandiari. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of Children's Health Defense. https://childrenshealthdefense.org/defender/truth-hpv-vaccine-part-2-et/ https://donshafi911.blogspot.com/2024/01/the-truth-about-hpv-vaccination-part-2.html
    CHILDRENSHEALTHDEFENSE.ORG
    The Truth About HPV Vaccination, Part 2: Studies Link the Vaccines to Neurological, Autoimmune Disorders
    Researchers who looked closely into the Gardasil HPV vaccine concluded the risks from the vaccine seem to significantly outweigh the as-yet-unproven long-term benefits.
    Like
    1
    0 Comments 0 Shares 15915 Views
  • The Truth About HPV Vaccination, Part 1: How Safe Is It, Really?
    This first installment in a multi-part series about the human papillomavirus, or HPV, vaccine explores peer-reviewed scientific literature that reveals serious safety concerns about a vaccine widely regarded as safe.

    The Epoch Times

    Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free.

    By Yuhong Dong

    The decline of public trust in COVID-19 vaccines significantly impacts vaccination rates against routine childhood diseases. This multiple-part series explores the international research done over the past two decades on the human papillomavirus (HPV) vaccine — believed to be one of the most effective vaccines developed to date.

    Summary of Key Facts

    This multiple-part series offers a thorough analysis of concerns raised about HPV vaccination following the global HPV campaign, which commenced in 2006.
    In the U.S., the HPV vaccine was reported to have a disproportionately higher percentage of adverse events of fainting and blood clots in the veins. The U.S. Food and Drug Administration (FDA) acknowledges that fainting can happen following the HPV vaccine, and recommends sitting or lying down to get the shot, then waiting for 15 minutes afterward.
    International scientists found that the Centers for Disease Control and Prevention’s (CDC) Vaccine Adverse Event Reporting System (VAERS) logged a substantial increase in reports of premature ovarian failure from 1.4 per year before 2006 to 22.2 per year after the HPV vaccine approval, yielding a Proportional Reporting Ratio of 46.1.
    The HPV vaccine is widely regarded as one of the most effective vaccines developed to date. Nevertheless, safety issues have been raised following its approval, and in response, additional research has been published and litigation has been brought on behalf of those with a vaccine injury.

    In this HPV vaccine series, Parts I and II explain how the vaccine works and the evidence suggesting there may be legitimate safety concerns. The remaining parts present questions about real-world vaccine effectiveness and identify specific ingredients which may pose harm.

    The information presented here is drawn from peer-reviewed scientific literature from the U.S., Australia, Denmark, Sweden, France and Japan, as well as statistics published by public health agencies in each of these countries.

    More than 100 hours of research and internal peer review among scientists with experience in infectious diseases, virology, clinical trials and vaccine epidemiology have been invested in presenting this summary of the evidence.

    Large registry-based studies have identified plausible associations between HPV vaccination and autoimmune conditions, including premature ovarian insufficiency or premature ovarian failure, Guillain-Barré syndrome (GBS), postural orthostatic tachycardia syndrome and chronic regional pain syndrome.

    While it is easy to be enthusiastic about recent advances in human vaccine technology, we should keep in mind that achieving real and lasting good health is much more than just the absence of a certain virus.

    RFK Jr. and Brian Hooker Vax-Unvax
    RFK Jr. and Brian Hooker’s New Book: “Vax-Unvax”

    Order Now

    What is HPV?

    According to the CDC, HPV is the most common sexually transmitted infection in the U.S.

    HPV is a small DNA virus infecting human cutaneous epithelial cells in the mucosa and skin. More than 150 strains of the HPV virus have been identified.

    HPV infection is so common that the majority of sexually active people will get it at some point in their lives, even if they have only one or very few sexual partners. It can spread through sexual intercourse and oral sex. It can also pass between people through skin-to-skin contact, even by people who have no symptoms.

    HPV infection causes genital warts, some of which can turn into cancer. For the most part, however, HPV infection is benign. More than 90% of HPV infections cause no clinical symptoms and are self-limited, meaning the virus is cleared by the body via natural immunological defenses.

    HPV-associated cancers

    High-risk HPV types (types 16, 18 and others) can cause cervical cell abnormalities that are precursors to cancers.

    Type 16 is associated with approximately 50% of cervical cancers worldwide, and types 16 and 18 together are linked to 66% of cervical cancers.

    An additional five high-risk types, 31, 33, 45, 52 and 58, are linked with another 15% of cervical cancers and 11% of all HPV-associated cancers.

    Infection with a high-risk HPV type is associated with a higher chance of the development of cervical cancer but, by itself, HPV infection is not the sole risk factor to cause cancer. There are many other reasons, as discussed in this paper.

    Given the prevalence of infection, it is unsurprising that globally, cervical cancer is the fourth most common cancer in women. In 2018, an estimated 570,000 women were diagnosed with cervical cancer worldwide and more than 300,000 died of the disease.

    In the U.S., nearly 50,000 new HPV-associated cancers occur annually, with women infected at a slightly higher rate than men.

    But in 9 out of 10 cases, HPV goes away within two years without causing health problems.

    Only persistent HPV infections may lead to cancer. These infections evade the immune system’s innate cell-mediated defenses.

    The incidence of cervical cancer can be controlled as a result of the implementation of routine testing and screening, including Pap and DNA tests.

    HPV vaccines

    Three HPV vaccines — bivalent HPV vaccine (Cervarix, 2vHPV), quadrivalent HPV vaccine (Gardasil, 4vHPV or HPV4) and 9-valent HPV vaccine (Gardasil 9, 9vHPV) — have been licensed by the FDA.

    The HPV vaccine uses recombinant technology to assemble the shell of the virus — L1 capsid protein. These viral-like particles do not contain the virus genome and are not infectious.

    Cervarix, developed by GlaxoSmithKline, is a bivalent vaccine against HPV types 16 and 18, that was pulled from the U.S. market in 2016 due to “very low market demand.”

    Merck’s original Gardasil vaccine was designed to prevent infections from four strains (types 6, 11, 16 and 18).

    On June 8, 2006, after the FDA’s fast-tracked review, Gardasil was approved for use in females ages 9 to 26 for the prevention of cervical, vulvar and vaginal cancers.

    According to the label accompanying the vaccine, the ingredients in Merck’s first Gardasil vaccine were proteins of HPV, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate and water for injection.

    On Oct. 16, 2009, the FDA approved Gardasil (HPV4) for use in boys ages 9 through 26 for the prevention of genital warts caused by HPV types 6 and 11, but not for cancer.

    In 2010, it approved Gardasil for the prevention of anal cancer in males and females ages 9 to 26.

    Four years later, the FDA approved an updated vaccine, Merck’s Gardasil 9, for use in girls ages 9 to 26 and boys ages 9 to 15 for the prevention of cervical, vaginal and anal cancers.

    Gardasil 9 contains the same ingredients as Gardasil, but offers protection against nine HPV strains, adding five additional types (HPV types 31, 33, 45, 52 and 58).

    The current HPV vaccination schedule recommended by the CDC is two doses for both boys and girls aged 11 or 12. However, it is approved for children as young as 9. The second dose is given 6 to 12 months after the first.

    For those aged 15 and above, a three-dose schedule is implemented at one- to two-month and six-month intervals, although antibody-level studies suggest that two doses are sufficient.

    The vaccine prompts the body to produce neutralizing antibodies against HPV. Antibody responses appear to peak seven months after the first dose (or one month after the third dose). The vaccine-induced antibody levels appear to be 10 to 100 times higher than those after natural infection.

    The high vaccine effectiveness (90 to 98%) against the fast-growing, abnormal cells which may cause precancerous lesions in people ages 16 to 26 suggested that the best timing for vaccination was to give it to patients before they became sexually active.

    HPV VAERS reports from 2 large countries

    U.S. HPV vaccine adverse events

    On Aug. 19, 2009, the Journal of the American Medical Association published an article authored by scientists from the FDA and CDC that reviewed the safety data for Gardasil for adverse events reported to VAERS between June 2006 through December 2008.

    During that time, there were 12,424 reports of adverse events. Of these, 772 (6.2%) were serious.

    VAERS is a passive surveillance system, which is subject to multiple limitations, including underreporting, unconfirmed diagnosis, lack of denominator data and no unbiased comparison groups.

    Nevertheless, it is a useful and important tool for detecting postmarket safety issues with vaccines.

    A disproportionately high percentage of Gardasil VAERS reports were of syncope (fainting) and venous thromboembolic events (blood clots in the veins) compared with other vaccines. There were 8.2 syncope events per 100,000 HPV doses and 0.2 venous thromboembolic events per 100,000 HPV doses reported, respectively.

    The Gardasil package insert includes a warning about fainting, fever, dizziness, nausea and headaches (page 1) and notes at least the following adverse reactions reported during postmarketing surveillance (section 6.2): Guillain-Barré syndrome, transverse myelitis, motor neuron disease, venous thromboembolic events, pancreatitis and autoimmune disorders.

    Australia HPV vaccines adverse events

    In 2007, Australia reported an annual adverse drug reaction rate of 7.3/100,000, the highest since 2003, representing an 85% increase from 2006.

    Per the analysis of the Adverse Drug Reactions System database by the Australian Department of Health and Aging, this increase was “almost entirely due to” reports following the national rollout of the three-dose HPV vaccination program for young females in April 2007; 705 of the 1,538 adverse drug reactions reported that year were from the Gardasil vaccine.

    1 vaccine adverse events australia chart
    In Australia, the ADR increase in 2007 was almost entirely due to the three-dose HPV vaccination program for females aged 12 to 26 years in April 2007. Credit: Australian Government Department of Health and Aged Care.
    Moreover, though people may take different vaccines other than HPV, the HPV vaccine was the only suspected vaccine to cause adverse reactions in 96% of records. Twenty-nine percent had causality ratings of “certain” or “probable” and 6% were defined as “serious.”

    2 vaccine types vaccine suspected chart
    In these HPV-induced ADRs, 674 were suspected to be related to HPV vaccines, 203 had causality ratings of “certain” or “probable,” and 43 were defined as “serious.” Credit: Australian Government Department of Health and Aged Care.
    Japan withdraws recommendation, vaccine acceptance plunged

    In 2013, the Japanese raised concerns about a variety of widely reported post-vaccination serious adverse events. This led the government to suspend recommending the HPV vaccine for six years. Vaccine acceptance of HPV in Japan plunged significantly after 2013, from 42.9% to 14.3%, or from 65.4% to 3.9%.

    Researchers around the world also started to investigate HPV safety. A World Health Organization (WHO) position paper released on July 14, 2017, concluded that the HPV vaccines were “extremely safe.”

    The same report estimated approximately 1.7 cases of anaphylaxis per million HPV doses, that no association with GBS was found, and that syncope (fainting) was “established as a common anxiety or stress-related reaction to the injection.”

    In the spring of 2022, Japan announced it was relaunching its HPV vaccination drive. Mainstream news outlets reported that for thousands of women, the cost of caution may have led to preventable HPV-induced cancers and an estimated 5,000 to 5,700 deaths.

    However, a true risk-benefit analysis would also consider the number of serious adverse events prevented by putting the program on hold. The question remains: Was Japan’s caution warranted, or should their national vaccination program have continued?

    Ovarian insufficiency

    Concerns that the vaccine may be negatively affecting fertility have been detailed in the scientific literature.

    In 2014, a peer-reviewed case series describing premature ovarian failure among Australian women following HPV vaccination was published in the Journal of Investigative Medicine.

    This prompted other researchers to systematically examine the VAERS data to see if there was a connection between premature ovarian failure and Gardasil. Their study found a “potential safety signal” and concluded that “further investigations are warranted.”

    VAERS analysis on ovarian failure

    Two recent publications based on VAERS reports (first study, second study) found that events with a probable autoimmune background were significantly more frequent after HPV vaccination compared to other vaccinations.

    The team of international scientists that did the second study evaluated reports between 1990 and 2018. They found that among the 228,341 premature ovarian failure reports, 0.1% was considered to be associated with HPV vaccination with a median age of 15 years and the time to onset was 20.5 days following vaccination.

    The primary symptoms were amenorrhea (80.4%) and premature menopause (15.3%).

    Most strikingly, the mean number of premature ovarian failure cases increased significantly from 1.4 per year prior to 2006 to 22.2 per year after the HPV vaccine was approved, with a proportional reporting ratio of 46.

    The investigators noted that the WHO and CDC declared the HPV vaccine safe regardless of lacking adequate research into safety concerns.

    For example, the authors note that in a CDC-sponsored VAERS study, 17 cases of premature ovarian failure were identified but 15 were excluded due to insufficient information to confirm the diagnosis. A separate observational study using the Vaccine Safety Datalink found no increased risk.

    But this study was too underpowered to detect a signal. In addition, a cross-sectional survey study using National Health and Nutrition Examination Survey data relied on an inaccurate measurement of premature ovarian failure and self-reported HPV vaccination.

    In summary, the researchers detected a strong safety signal even after accounting for a potential upswing in reports due to media coverage after the product launch (they refer to this as “notoriety bias”).

    Because VAERS is a passive reporting system, the data may be incomplete and are often unconfirmed by physicians. Therefore, this study cannot provide a definitive link between HPV vaccination and premature ovarian insufficiency or premature ovarian failure but does generate a hypothetical link.

    The authors of the second study conclude by insisting that “this signal warrants well-designed and appropriate epidemiological research.” They note that “if the signal is confirmed, the risk is small compared to the lifetime risk of cervical cancer.”

    However, the benefit-risk profile on an individual level is not uniform.

    Given the health impacts of premature ovarian insufficiency and premature ovarian failure — some of which may be irreversible — and the declining mortality rate for cervical cancer even in the prevaccine era, the risk-benefit profile for HPV vaccination remains unclear.

    3 case reports on ovarian insufficiency

    In the 2014 investigation mentioned above, a general practitioner in Australia noticed that three girls developed premature ovarian insufficiency following HPV4 vaccination.

    As a result of vaccination, each of the girls (ages 16, 16 and 18) had been prescribed oral contraception to treat menstrual cycle irregularities. Typically, women present with amenorrhea (no periods) or oligomenorrhea (infrequent periods) as the initial symptom of premature ovarian insufficiency.

    One girl had irregular periods following three doses of HPV vaccination. She then became amenorrheic and was diagnosed with premature ovarian insufficiency.

    Another girl’s periods were “like clockwork” until after the third HPV dose, which she received at age 15. Her first cycle after being vaccinated for the third time started two weeks late, and her next cycle was two months late. The final cycle began nine months later. The patient had no family history of early menopause.

    She was diagnosed with premature ovarian failure at 16. Lab work found hormone levels consistent with those of postmenopausal women, but her bone mineral density was normal.

    The authors of this case series noted that in preclinical studies of HPV4, the five-week-old rats only conceived one litter and the only available toxicology studies appear to be on the male rodent reproductive system.

    However, only two of three doses were administered prior to mating, and the overall fecundity was 95%, slightly lower than the control rats (98%) that received no vaccination prior to mating.

    The dose tolerance recommendations were based on an average weight of 50 kilograms for an adolescent girl but failed to take into account that HPV4 is administered to girls ages 9 to 13 years, who range in weight from 28 to 46 kilograms.

    Danish retrospective cohort study finds no link

    A 2021 study also evaluated premature ovarian insufficiency in a nationwide cohort of nearly 1 million Danish females ages 11 to 34 years.

    The researchers used Cox proportional hazard regression to detect an increased risk of premature ovarian insufficiency diagnosis by HPV4 vaccination status during the years 2007-2016. The hazard ratio for premature ovarian insufficiency (vaccinated versus unvaccinated) was 0.96.

    One limitation was that data on age at menarche (first menstruation) and oral contraceptive use were not available. Girls who had not yet reached menarche would not be at risk for premature ovarian insufficiency, of course.

    The authors excluded girls under age 15 in a sensitivity analysis and still found no signal, concluding that no association was found between HPV4 vaccination and premature ovarian insufficiency.

    Reprinted with permission from The Epoch Times. Dr. Yuhong Dong, a medical doctor who also holds a doctorate in infectious diseases from China, is the chief scientific officer and co-founder of a Swiss biotech company and a former senior medical scientific expert for antiviral drug development at Novartis Pharma in Switzerland.

    If you or your child suffered harm after receiving the Gardasil HPV vaccine, you may have a legal claim. Please visit Wisner Baum for a free case evaluation. Click here to watch a Gardasil litigation update interview with Wisner Baum Senior Partner Bijan Esfandiari.

    The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of Children's Health Defense.

    https://childrenshealthdefense.org/defender/hpv-vaccine-safety-concerns-part-1-et/


    https://donshafi911.blogspot.com/2024/01/the-truth-about-hpv-vaccination-part-1.html
    The Truth About HPV Vaccination, Part 1: How Safe Is It, Really? This first installment in a multi-part series about the human papillomavirus, or HPV, vaccine explores peer-reviewed scientific literature that reveals serious safety concerns about a vaccine widely regarded as safe. The Epoch Times Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free. By Yuhong Dong The decline of public trust in COVID-19 vaccines significantly impacts vaccination rates against routine childhood diseases. This multiple-part series explores the international research done over the past two decades on the human papillomavirus (HPV) vaccine — believed to be one of the most effective vaccines developed to date. Summary of Key Facts This multiple-part series offers a thorough analysis of concerns raised about HPV vaccination following the global HPV campaign, which commenced in 2006. In the U.S., the HPV vaccine was reported to have a disproportionately higher percentage of adverse events of fainting and blood clots in the veins. The U.S. Food and Drug Administration (FDA) acknowledges that fainting can happen following the HPV vaccine, and recommends sitting or lying down to get the shot, then waiting for 15 minutes afterward. International scientists found that the Centers for Disease Control and Prevention’s (CDC) Vaccine Adverse Event Reporting System (VAERS) logged a substantial increase in reports of premature ovarian failure from 1.4 per year before 2006 to 22.2 per year after the HPV vaccine approval, yielding a Proportional Reporting Ratio of 46.1. The HPV vaccine is widely regarded as one of the most effective vaccines developed to date. Nevertheless, safety issues have been raised following its approval, and in response, additional research has been published and litigation has been brought on behalf of those with a vaccine injury. In this HPV vaccine series, Parts I and II explain how the vaccine works and the evidence suggesting there may be legitimate safety concerns. The remaining parts present questions about real-world vaccine effectiveness and identify specific ingredients which may pose harm. The information presented here is drawn from peer-reviewed scientific literature from the U.S., Australia, Denmark, Sweden, France and Japan, as well as statistics published by public health agencies in each of these countries. More than 100 hours of research and internal peer review among scientists with experience in infectious diseases, virology, clinical trials and vaccine epidemiology have been invested in presenting this summary of the evidence. Large registry-based studies have identified plausible associations between HPV vaccination and autoimmune conditions, including premature ovarian insufficiency or premature ovarian failure, Guillain-Barré syndrome (GBS), postural orthostatic tachycardia syndrome and chronic regional pain syndrome. While it is easy to be enthusiastic about recent advances in human vaccine technology, we should keep in mind that achieving real and lasting good health is much more than just the absence of a certain virus. RFK Jr. and Brian Hooker Vax-Unvax RFK Jr. and Brian Hooker’s New Book: “Vax-Unvax” Order Now What is HPV? According to the CDC, HPV is the most common sexually transmitted infection in the U.S. HPV is a small DNA virus infecting human cutaneous epithelial cells in the mucosa and skin. More than 150 strains of the HPV virus have been identified. HPV infection is so common that the majority of sexually active people will get it at some point in their lives, even if they have only one or very few sexual partners. It can spread through sexual intercourse and oral sex. It can also pass between people through skin-to-skin contact, even by people who have no symptoms. HPV infection causes genital warts, some of which can turn into cancer. For the most part, however, HPV infection is benign. More than 90% of HPV infections cause no clinical symptoms and are self-limited, meaning the virus is cleared by the body via natural immunological defenses. HPV-associated cancers High-risk HPV types (types 16, 18 and others) can cause cervical cell abnormalities that are precursors to cancers. Type 16 is associated with approximately 50% of cervical cancers worldwide, and types 16 and 18 together are linked to 66% of cervical cancers. An additional five high-risk types, 31, 33, 45, 52 and 58, are linked with another 15% of cervical cancers and 11% of all HPV-associated cancers. Infection with a high-risk HPV type is associated with a higher chance of the development of cervical cancer but, by itself, HPV infection is not the sole risk factor to cause cancer. There are many other reasons, as discussed in this paper. Given the prevalence of infection, it is unsurprising that globally, cervical cancer is the fourth most common cancer in women. In 2018, an estimated 570,000 women were diagnosed with cervical cancer worldwide and more than 300,000 died of the disease. In the U.S., nearly 50,000 new HPV-associated cancers occur annually, with women infected at a slightly higher rate than men. But in 9 out of 10 cases, HPV goes away within two years without causing health problems. Only persistent HPV infections may lead to cancer. These infections evade the immune system’s innate cell-mediated defenses. The incidence of cervical cancer can be controlled as a result of the implementation of routine testing and screening, including Pap and DNA tests. HPV vaccines Three HPV vaccines — bivalent HPV vaccine (Cervarix, 2vHPV), quadrivalent HPV vaccine (Gardasil, 4vHPV or HPV4) and 9-valent HPV vaccine (Gardasil 9, 9vHPV) — have been licensed by the FDA. The HPV vaccine uses recombinant technology to assemble the shell of the virus — L1 capsid protein. These viral-like particles do not contain the virus genome and are not infectious. Cervarix, developed by GlaxoSmithKline, is a bivalent vaccine against HPV types 16 and 18, that was pulled from the U.S. market in 2016 due to “very low market demand.” Merck’s original Gardasil vaccine was designed to prevent infections from four strains (types 6, 11, 16 and 18). On June 8, 2006, after the FDA’s fast-tracked review, Gardasil was approved for use in females ages 9 to 26 for the prevention of cervical, vulvar and vaginal cancers. According to the label accompanying the vaccine, the ingredients in Merck’s first Gardasil vaccine were proteins of HPV, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate and water for injection. On Oct. 16, 2009, the FDA approved Gardasil (HPV4) for use in boys ages 9 through 26 for the prevention of genital warts caused by HPV types 6 and 11, but not for cancer. In 2010, it approved Gardasil for the prevention of anal cancer in males and females ages 9 to 26. Four years later, the FDA approved an updated vaccine, Merck’s Gardasil 9, for use in girls ages 9 to 26 and boys ages 9 to 15 for the prevention of cervical, vaginal and anal cancers. Gardasil 9 contains the same ingredients as Gardasil, but offers protection against nine HPV strains, adding five additional types (HPV types 31, 33, 45, 52 and 58). The current HPV vaccination schedule recommended by the CDC is two doses for both boys and girls aged 11 or 12. However, it is approved for children as young as 9. The second dose is given 6 to 12 months after the first. For those aged 15 and above, a three-dose schedule is implemented at one- to two-month and six-month intervals, although antibody-level studies suggest that two doses are sufficient. The vaccine prompts the body to produce neutralizing antibodies against HPV. Antibody responses appear to peak seven months after the first dose (or one month after the third dose). The vaccine-induced antibody levels appear to be 10 to 100 times higher than those after natural infection. The high vaccine effectiveness (90 to 98%) against the fast-growing, abnormal cells which may cause precancerous lesions in people ages 16 to 26 suggested that the best timing for vaccination was to give it to patients before they became sexually active. HPV VAERS reports from 2 large countries U.S. HPV vaccine adverse events On Aug. 19, 2009, the Journal of the American Medical Association published an article authored by scientists from the FDA and CDC that reviewed the safety data for Gardasil for adverse events reported to VAERS between June 2006 through December 2008. During that time, there were 12,424 reports of adverse events. Of these, 772 (6.2%) were serious. VAERS is a passive surveillance system, which is subject to multiple limitations, including underreporting, unconfirmed diagnosis, lack of denominator data and no unbiased comparison groups. Nevertheless, it is a useful and important tool for detecting postmarket safety issues with vaccines. A disproportionately high percentage of Gardasil VAERS reports were of syncope (fainting) and venous thromboembolic events (blood clots in the veins) compared with other vaccines. There were 8.2 syncope events per 100,000 HPV doses and 0.2 venous thromboembolic events per 100,000 HPV doses reported, respectively. The Gardasil package insert includes a warning about fainting, fever, dizziness, nausea and headaches (page 1) and notes at least the following adverse reactions reported during postmarketing surveillance (section 6.2): Guillain-Barré syndrome, transverse myelitis, motor neuron disease, venous thromboembolic events, pancreatitis and autoimmune disorders. Australia HPV vaccines adverse events In 2007, Australia reported an annual adverse drug reaction rate of 7.3/100,000, the highest since 2003, representing an 85% increase from 2006. Per the analysis of the Adverse Drug Reactions System database by the Australian Department of Health and Aging, this increase was “almost entirely due to” reports following the national rollout of the three-dose HPV vaccination program for young females in April 2007; 705 of the 1,538 adverse drug reactions reported that year were from the Gardasil vaccine. 1 vaccine adverse events australia chart In Australia, the ADR increase in 2007 was almost entirely due to the three-dose HPV vaccination program for females aged 12 to 26 years in April 2007. Credit: Australian Government Department of Health and Aged Care. Moreover, though people may take different vaccines other than HPV, the HPV vaccine was the only suspected vaccine to cause adverse reactions in 96% of records. Twenty-nine percent had causality ratings of “certain” or “probable” and 6% were defined as “serious.” 2 vaccine types vaccine suspected chart In these HPV-induced ADRs, 674 were suspected to be related to HPV vaccines, 203 had causality ratings of “certain” or “probable,” and 43 were defined as “serious.” Credit: Australian Government Department of Health and Aged Care. Japan withdraws recommendation, vaccine acceptance plunged In 2013, the Japanese raised concerns about a variety of widely reported post-vaccination serious adverse events. This led the government to suspend recommending the HPV vaccine for six years. Vaccine acceptance of HPV in Japan plunged significantly after 2013, from 42.9% to 14.3%, or from 65.4% to 3.9%. Researchers around the world also started to investigate HPV safety. A World Health Organization (WHO) position paper released on July 14, 2017, concluded that the HPV vaccines were “extremely safe.” The same report estimated approximately 1.7 cases of anaphylaxis per million HPV doses, that no association with GBS was found, and that syncope (fainting) was “established as a common anxiety or stress-related reaction to the injection.” In the spring of 2022, Japan announced it was relaunching its HPV vaccination drive. Mainstream news outlets reported that for thousands of women, the cost of caution may have led to preventable HPV-induced cancers and an estimated 5,000 to 5,700 deaths. However, a true risk-benefit analysis would also consider the number of serious adverse events prevented by putting the program on hold. The question remains: Was Japan’s caution warranted, or should their national vaccination program have continued? Ovarian insufficiency Concerns that the vaccine may be negatively affecting fertility have been detailed in the scientific literature. In 2014, a peer-reviewed case series describing premature ovarian failure among Australian women following HPV vaccination was published in the Journal of Investigative Medicine. This prompted other researchers to systematically examine the VAERS data to see if there was a connection between premature ovarian failure and Gardasil. Their study found a “potential safety signal” and concluded that “further investigations are warranted.” VAERS analysis on ovarian failure Two recent publications based on VAERS reports (first study, second study) found that events with a probable autoimmune background were significantly more frequent after HPV vaccination compared to other vaccinations. The team of international scientists that did the second study evaluated reports between 1990 and 2018. They found that among the 228,341 premature ovarian failure reports, 0.1% was considered to be associated with HPV vaccination with a median age of 15 years and the time to onset was 20.5 days following vaccination. The primary symptoms were amenorrhea (80.4%) and premature menopause (15.3%). Most strikingly, the mean number of premature ovarian failure cases increased significantly from 1.4 per year prior to 2006 to 22.2 per year after the HPV vaccine was approved, with a proportional reporting ratio of 46. The investigators noted that the WHO and CDC declared the HPV vaccine safe regardless of lacking adequate research into safety concerns. For example, the authors note that in a CDC-sponsored VAERS study, 17 cases of premature ovarian failure were identified but 15 were excluded due to insufficient information to confirm the diagnosis. A separate observational study using the Vaccine Safety Datalink found no increased risk. But this study was too underpowered to detect a signal. In addition, a cross-sectional survey study using National Health and Nutrition Examination Survey data relied on an inaccurate measurement of premature ovarian failure and self-reported HPV vaccination. In summary, the researchers detected a strong safety signal even after accounting for a potential upswing in reports due to media coverage after the product launch (they refer to this as “notoriety bias”). Because VAERS is a passive reporting system, the data may be incomplete and are often unconfirmed by physicians. Therefore, this study cannot provide a definitive link between HPV vaccination and premature ovarian insufficiency or premature ovarian failure but does generate a hypothetical link. The authors of the second study conclude by insisting that “this signal warrants well-designed and appropriate epidemiological research.” They note that “if the signal is confirmed, the risk is small compared to the lifetime risk of cervical cancer.” However, the benefit-risk profile on an individual level is not uniform. Given the health impacts of premature ovarian insufficiency and premature ovarian failure — some of which may be irreversible — and the declining mortality rate for cervical cancer even in the prevaccine era, the risk-benefit profile for HPV vaccination remains unclear. 3 case reports on ovarian insufficiency In the 2014 investigation mentioned above, a general practitioner in Australia noticed that three girls developed premature ovarian insufficiency following HPV4 vaccination. As a result of vaccination, each of the girls (ages 16, 16 and 18) had been prescribed oral contraception to treat menstrual cycle irregularities. Typically, women present with amenorrhea (no periods) or oligomenorrhea (infrequent periods) as the initial symptom of premature ovarian insufficiency. One girl had irregular periods following three doses of HPV vaccination. She then became amenorrheic and was diagnosed with premature ovarian insufficiency. Another girl’s periods were “like clockwork” until after the third HPV dose, which she received at age 15. Her first cycle after being vaccinated for the third time started two weeks late, and her next cycle was two months late. The final cycle began nine months later. The patient had no family history of early menopause. She was diagnosed with premature ovarian failure at 16. Lab work found hormone levels consistent with those of postmenopausal women, but her bone mineral density was normal. The authors of this case series noted that in preclinical studies of HPV4, the five-week-old rats only conceived one litter and the only available toxicology studies appear to be on the male rodent reproductive system. However, only two of three doses were administered prior to mating, and the overall fecundity was 95%, slightly lower than the control rats (98%) that received no vaccination prior to mating. The dose tolerance recommendations were based on an average weight of 50 kilograms for an adolescent girl but failed to take into account that HPV4 is administered to girls ages 9 to 13 years, who range in weight from 28 to 46 kilograms. Danish retrospective cohort study finds no link A 2021 study also evaluated premature ovarian insufficiency in a nationwide cohort of nearly 1 million Danish females ages 11 to 34 years. The researchers used Cox proportional hazard regression to detect an increased risk of premature ovarian insufficiency diagnosis by HPV4 vaccination status during the years 2007-2016. The hazard ratio for premature ovarian insufficiency (vaccinated versus unvaccinated) was 0.96. One limitation was that data on age at menarche (first menstruation) and oral contraceptive use were not available. Girls who had not yet reached menarche would not be at risk for premature ovarian insufficiency, of course. The authors excluded girls under age 15 in a sensitivity analysis and still found no signal, concluding that no association was found between HPV4 vaccination and premature ovarian insufficiency. Reprinted with permission from The Epoch Times. Dr. Yuhong Dong, a medical doctor who also holds a doctorate in infectious diseases from China, is the chief scientific officer and co-founder of a Swiss biotech company and a former senior medical scientific expert for antiviral drug development at Novartis Pharma in Switzerland. If you or your child suffered harm after receiving the Gardasil HPV vaccine, you may have a legal claim. Please visit Wisner Baum for a free case evaluation. Click here to watch a Gardasil litigation update interview with Wisner Baum Senior Partner Bijan Esfandiari. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of Children's Health Defense. https://childrenshealthdefense.org/defender/hpv-vaccine-safety-concerns-part-1-et/ https://donshafi911.blogspot.com/2024/01/the-truth-about-hpv-vaccination-part-1.html
    CHILDRENSHEALTHDEFENSE.ORG
    The Truth About HPV Vaccination, Part 1: How Safe Is It, Really?
    This first installment in a multi-part series about the human papillomavirus, or HPV, vaccine explores peer-reviewed scientific literature that reveals serious safety concerns about a vaccine widely regarded as safe.
    Like
    1
    0 Comments 1 Shares 20618 Views
  • mRNA Vaccines Contain Prion Region, May Be Linked to Prion-Like Diseases
    As pathogenic prions accumulate, people may start to develop prion diseases such as Creutzfeldt-Jakob disease and mad cow disease.

    mRNA Vaccines Contain Prion Region, May Be Linked to Prion-Like Diseases
    (Signal Scientific Visuals/Shutterstock)
    The COVID-19 virus and its vaccine sequences have a prion region on their surface spike proteins. Earlier in the pandemic and vaccine rollout, some researchers were concerned that these prion regions may promote incurable prion diseases, such as Creutzfeldt-Jakob disease (CJD).

    In December 2023, researchers from Oxford showed that 8 percent of the time, the body does not make spike protein from Pfizer mRNA vaccines but may form aberrant proteins instead. This has led researchers to investigate the potential risks of such unintentional formations.
    Subsequently, on Jan. 12, retired French biomathematician Jean-Claude Perez published a preprint study discussing whether such mistakes could lead to the formation of prion-like proteins. He concluded that prion-like protein formation is possible.
    A previous peer-reviewed paper by Mr. Perez and his co-authors in January 2023 recorded 26 cases of CJD. Those afflicted reported that their first symptoms manifested within one to 31 days of their last COVID-19 vaccination or infection.
    All patients experienced a rapid worsening of their condition over the ensuing months and died.
    What Are Prions?

    Prions are proteins that exist naturally in the brain. They perform crucial tasks and are necessary for human health.

    However, on rare occasions, a healthy prion may misfold into a pathogenic prion. This misfold is irreversible, and from then on, the pathogenic prion converts all healthy prions it encounters into pathogenic prions.

    As pathogenic prions accumulate, people may start to develop prion diseases such as CJD and mad cow disease.
    Other researchers have also proposed that Parkinson’s disease and Alzheimer’s disease, both of which exhibit an accumulation of misfolded proteins, may also be prion diseases.

    Prions are defined by their amino acid sequences. Prion-like sequences are rich in glutamine and asparagine amino acids, and human or foreign proteins that contain such regions are at risk of initiating prion diseases.

    “Amino acid sequence can tell us if a protein can potentially act as a prion and show prion-like functions,” said Vladimir Uversky, PhD, a professor at the University of South Florida specializing in molecular medicine. “Not all proteins with prion-like sequences will undoubtedly act as prions. Even prion protein itself will cause prion disease in very few cases.

    “If, however, one got such proteins, then there is a chance that [the proteins] can trigger some pathology. It is not clear when, how, and with what probability this would happen, but the overall chances of getting something bad are definitely increased,” Mr. Uversky told The Epoch Times, comparing the prion protein to “a time bomb with a dysfunctional or stochastic timer.”
    How Would mRNA Vaccines Form Prion Proteins?

    One can think of mRNA vaccines as instructions used to make spike proteins. In the case of COVID-19 vaccines, the mRNA vaccines contain a high percentage of pseudouridine, which is less common in the human body. The extra pseudouridine makes the process more prone to “frameshift errors.”

    Frameshift errors occur when the cell’s protein production machinery accidentally misses one or two bases in the mRNA sequence. Since mRNA bases are read in groups of threes, a frameshift breaks up the original sets of the sequence, affecting all sequences downstream of the error.

    In his research, Mr. Perez found a frameshift by one base retains the prion-like sequences, while a frameshift by two bases eliminates them.

    He also found that the frameshift sequences share similarities to bacterial proteins on the brain-eating amoeba and human nuclease proteins, proteins capable of breaking apart DNA bonds.
    Spike Proteins and Prion Diseases in the Literature

    Numerous papers in the literature have linked COVID-19 spike protein to prion formations.

    The spike protein naturally has a prion-like domain at the region where it binds to other receptors. SARS-CoV-2 is the only coronavirus with a prion-like domain in its spike protein.
    In September 2023, Swedish researchers published a preprint finding that spike proteins may accelerate Alzheimer’s and prion disease formation.
    The authors found specific spike protein sequences carried amyloid sequences and extracted them. When these sequences were supplemented with human prion and amyloid proteins, the spike sequences accelerated the proteins’ aggregation.

    Neurologist Dr. Suzanne Gazda told The Epoch Times she is very concerned about the implications of prion disease acceleration and formation due to COVID-19 vaccination and infections.

    Another study published in October 2023 found that spike protein can bind to alpha-synuclein, an unfolded protein that accumulates in Parkinson’s disease. The authors found that introducing spike protein to alpha-synuclein also increased its aggregation.
    Several studies have linked COVID-19 and its vaccines with prion diseases.

    A Turkish case study detailed the case of a 68-year-old man who developed symptoms of CJD weeks after being administered the COVID mRNA vaccine.
    Around one to two weeks after administration, he became forgetful; two months later, he began losing his ability to find words. By the third to fourth month, he had developed a progressive speech disorder, confusion, agitation, and involuntary contraction of his left arm and leg.

    A 2022 Italian case report examined the case of a man in his early 40s who developed CJD two months after a mild COVID-19 infection. He first started seeing black shadows when closing his eyes, “followed by dizziness, difficulty reading and worsening of balance,” the authors wrote.
    Three months post-infection, the patient reported loss of coordination in his left arm and loss of reflexes in his legs.

    https://www.theepochtimes.com/health/mrna-vaccines-contain-prion-region-may-be-linked-to-prion-like-diseases-5573131
    mRNA Vaccines Contain Prion Region, May Be Linked to Prion-Like Diseases As pathogenic prions accumulate, people may start to develop prion diseases such as Creutzfeldt-Jakob disease and mad cow disease. mRNA Vaccines Contain Prion Region, May Be Linked to Prion-Like Diseases (Signal Scientific Visuals/Shutterstock) The COVID-19 virus and its vaccine sequences have a prion region on their surface spike proteins. Earlier in the pandemic and vaccine rollout, some researchers were concerned that these prion regions may promote incurable prion diseases, such as Creutzfeldt-Jakob disease (CJD). In December 2023, researchers from Oxford showed that 8 percent of the time, the body does not make spike protein from Pfizer mRNA vaccines but may form aberrant proteins instead. This has led researchers to investigate the potential risks of such unintentional formations. Subsequently, on Jan. 12, retired French biomathematician Jean-Claude Perez published a preprint study discussing whether such mistakes could lead to the formation of prion-like proteins. He concluded that prion-like protein formation is possible. A previous peer-reviewed paper by Mr. Perez and his co-authors in January 2023 recorded 26 cases of CJD. Those afflicted reported that their first symptoms manifested within one to 31 days of their last COVID-19 vaccination or infection. All patients experienced a rapid worsening of their condition over the ensuing months and died. What Are Prions? Prions are proteins that exist naturally in the brain. They perform crucial tasks and are necessary for human health. However, on rare occasions, a healthy prion may misfold into a pathogenic prion. This misfold is irreversible, and from then on, the pathogenic prion converts all healthy prions it encounters into pathogenic prions. As pathogenic prions accumulate, people may start to develop prion diseases such as CJD and mad cow disease. Other researchers have also proposed that Parkinson’s disease and Alzheimer’s disease, both of which exhibit an accumulation of misfolded proteins, may also be prion diseases. Prions are defined by their amino acid sequences. Prion-like sequences are rich in glutamine and asparagine amino acids, and human or foreign proteins that contain such regions are at risk of initiating prion diseases. “Amino acid sequence can tell us if a protein can potentially act as a prion and show prion-like functions,” said Vladimir Uversky, PhD, a professor at the University of South Florida specializing in molecular medicine. “Not all proteins with prion-like sequences will undoubtedly act as prions. Even prion protein itself will cause prion disease in very few cases. “If, however, one got such proteins, then there is a chance that [the proteins] can trigger some pathology. It is not clear when, how, and with what probability this would happen, but the overall chances of getting something bad are definitely increased,” Mr. Uversky told The Epoch Times, comparing the prion protein to “a time bomb with a dysfunctional or stochastic timer.” How Would mRNA Vaccines Form Prion Proteins? One can think of mRNA vaccines as instructions used to make spike proteins. In the case of COVID-19 vaccines, the mRNA vaccines contain a high percentage of pseudouridine, which is less common in the human body. The extra pseudouridine makes the process more prone to “frameshift errors.” Frameshift errors occur when the cell’s protein production machinery accidentally misses one or two bases in the mRNA sequence. Since mRNA bases are read in groups of threes, a frameshift breaks up the original sets of the sequence, affecting all sequences downstream of the error. In his research, Mr. Perez found a frameshift by one base retains the prion-like sequences, while a frameshift by two bases eliminates them. He also found that the frameshift sequences share similarities to bacterial proteins on the brain-eating amoeba and human nuclease proteins, proteins capable of breaking apart DNA bonds. Spike Proteins and Prion Diseases in the Literature Numerous papers in the literature have linked COVID-19 spike protein to prion formations. The spike protein naturally has a prion-like domain at the region where it binds to other receptors. SARS-CoV-2 is the only coronavirus with a prion-like domain in its spike protein. In September 2023, Swedish researchers published a preprint finding that spike proteins may accelerate Alzheimer’s and prion disease formation. The authors found specific spike protein sequences carried amyloid sequences and extracted them. When these sequences were supplemented with human prion and amyloid proteins, the spike sequences accelerated the proteins’ aggregation. Neurologist Dr. Suzanne Gazda told The Epoch Times she is very concerned about the implications of prion disease acceleration and formation due to COVID-19 vaccination and infections. Another study published in October 2023 found that spike protein can bind to alpha-synuclein, an unfolded protein that accumulates in Parkinson’s disease. The authors found that introducing spike protein to alpha-synuclein also increased its aggregation. Several studies have linked COVID-19 and its vaccines with prion diseases. A Turkish case study detailed the case of a 68-year-old man who developed symptoms of CJD weeks after being administered the COVID mRNA vaccine. Around one to two weeks after administration, he became forgetful; two months later, he began losing his ability to find words. By the third to fourth month, he had developed a progressive speech disorder, confusion, agitation, and involuntary contraction of his left arm and leg. A 2022 Italian case report examined the case of a man in his early 40s who developed CJD two months after a mild COVID-19 infection. He first started seeing black shadows when closing his eyes, “followed by dizziness, difficulty reading and worsening of balance,” the authors wrote. Three months post-infection, the patient reported loss of coordination in his left arm and loss of reflexes in his legs. https://www.theepochtimes.com/health/mrna-vaccines-contain-prion-region-may-be-linked-to-prion-like-diseases-5573131
    WWW.THEEPOCHTIMES.COM
    mRNA Vaccines Contain Prion Region, May Be Linked to Prion-Like Diseases
    As pathogenic prions accumulate, people may start to develop prion diseases such as Creutzfeldt-Jakob disease and mad cow disease.
    Angry
    1
    0 Comments 1 Shares 6686 Views
  • 3 Additional Chemicals Discovered on East Palestine Train Derailment

    “We basically nuked a town with chemicals so we could get a railroad open,” said Sil Caggiano, a hazardous materials specialist.

    First News was recently informed of three more chemicals that were on the Norfolk Southern train that derailed in East Palestine just over a week ago — and we are being told that those chemicals are dangerous.

    The U.S. Environmental Protection Agency sent a letter to Norfolk Southern stating that ethylene glycol monobutyl ether, ethylhexyl acrylate and isobutylene were also in the rail cars that were derailed, breached and/or on fire.

    Caggiano says ethylhexyl acrylate is especially worrisome. He says it’s a carcinogen and contact with it can cause burning and irritation in the skin and eyes. Breathing it in can irritate the nose and throat and cause coughing and shortness of breath.

    Isobutylene is also known to cause dizziness and drowsiness when inhaled.

    “I was surprised when they quickly told the people they can go back home, but then said if they feel like they want their homes tested they can have them tested. I would’ve far rather they did all the testing,” Caggiano said.

    Caggiano says it’s possible some of these chemicals could still be present in homes and on objects until you clean them thoroughly.

    “There’s a lot of what ifs, and we’re going to be looking at this thing 5, 10, 15, 20 years down the line and wondering, ‘Gee, cancer clusters could pop up, you know, well water could go bad,” Caggiano said.

    ????Source: WKBN (https://www.wkbn.com/news/local-news/east-palestine-train-derailment/3-additional-chemicals-discovered-on-east-palestine-train-derailment/)

    ???? Follow:
    @G3News t.me/g3news
    3 Additional Chemicals Discovered on East Palestine Train Derailment “We basically nuked a town with chemicals so we could get a railroad open,” said Sil Caggiano, a hazardous materials specialist. First News was recently informed of three more chemicals that were on the Norfolk Southern train that derailed in East Palestine just over a week ago — and we are being told that those chemicals are dangerous. The U.S. Environmental Protection Agency sent a letter to Norfolk Southern stating that ethylene glycol monobutyl ether, ethylhexyl acrylate and isobutylene were also in the rail cars that were derailed, breached and/or on fire. Caggiano says ethylhexyl acrylate is especially worrisome. He says it’s a carcinogen and contact with it can cause burning and irritation in the skin and eyes. Breathing it in can irritate the nose and throat and cause coughing and shortness of breath. Isobutylene is also known to cause dizziness and drowsiness when inhaled. “I was surprised when they quickly told the people they can go back home, but then said if they feel like they want their homes tested they can have them tested. I would’ve far rather they did all the testing,” Caggiano said. Caggiano says it’s possible some of these chemicals could still be present in homes and on objects until you clean them thoroughly. “There’s a lot of what ifs, and we’re going to be looking at this thing 5, 10, 15, 20 years down the line and wondering, ‘Gee, cancer clusters could pop up, you know, well water could go bad,” Caggiano said. ????Source: WKBN (https://www.wkbn.com/news/local-news/east-palestine-train-derailment/3-additional-chemicals-discovered-on-east-palestine-train-derailment/) ???? Follow: @G3News t.me/g3news
    WWW.WKBN.COM
    3 additional chemicals discovered on East Palestine train derailment
    First News was recently informed of three more chemicals that were on the Norfolk Southern train that derailed in East Palestine just over a week ago — and we are being told that those chemic…
    Like
    4
    0 Comments 0 Shares 1792 Views
  • Hemp is a plant that represents abundance in more ways than one. It grows abundantly with thick, lush green foliage and offers a myriad number of benefits with its high nutrition and therapeutic benefits.
    Our ancestors realized its benefits thousands of years ago and it is being cultivated since then. Modern research has further attested to this plant&rsquo;s constituents and nutritional profile and the numerous health benefit that it offers.
    Top 12 medicinal Usages or benefits of hemp.

    Hemp for your heart
    Hemp seeds or oil contain an amino acid known as arginine which is extremely good for your heart as it dilates and relaxes your blood vessels. Hemp oil fights inflammation, lowers blood pressure, and prevents the formation of blood clots.
    Hemp is a rich source of Gamma-Linoleic Acid
    Hemp seeds are a rich source of gamma-linolenic acid (GLA), which is known for its strong anti-inflammatory properties. Foods rich in GLA are extensively used to fight inflammation in the joints (arthritis), nerve damage, and inflamed skin conditions such as acne, and eczema.
    Hemp can help you with your stress
    Hemp seed helps in a variety of diseases. Anxiety caused by pain or health conditions as such can be efficiently dealt with hemp as it can alleviate those conditions.
    Furthermore, hemp seeds contain an impressive amount of magnesium and B vitamins which can help the body manage stress by impacting neurotransmitters (chemical messenger which transmits signals released by neurons to stimulate other neurons or muscle or gland cells.
    Protect the brain
    Studies have found that hemp seed extract has antioxidant effects owing to its cannabidiol (CBD) content which regulates the immune system and could help in neurological conditions such as Parkinson&rsquo;s disease, multiple sclerosis, neuropathic pain, Alzheimer&rsquo;s disease, etc.
    Improve skin conditions
    Atopic dermatitis (AD) and acne can both result from chronic inflammation, which results from a deficiency in omega-3.
    Hemp seeds are a rich source of plant fiber and omega-3 fatty acid along with vitamins such as A and E and minerals such as calcium, iron, zinc, magnesium, and phosphorus, which all help to keep the skin moisturized, soft, supple and disease-free.
    Repair and regeneration
    Hemp seeds contain as much protein as soybeans. They provide all nine essential amino acids which are used as building blocks for repair and regeneration across the body.
    Excellent for the digestive system
    fibers are excellent for our digestion system. Fibres help in constipation, weight management, nourishment of healthy bacteria in our guts, stabilizes blood sugar level and helps fight cholesterol.
    Hemp relieves pain
    Hemp possesses strong anti-inflammatory properties. It is therefore highly useful in relieving pain resulting from an injury, infection or any autoimmunity disorder.
    Help with Hormones
    As mentioned above hemp seed contains a rich amount of GLA which can ease hormonal &ldquo;mood swings&rdquo; during periods through stimulation of certain prostaglandins.
    Relieve rheumatoid arthritis
    Rheumatoid arthritis refers to inflammation in the joints resulting from immune attacking its tissues. Cannabinoids present in hemp seed oil have anti-rheumatic effects.
    Effective in treating anemia
    Anemia is a condition arising out of iron deficiency. Anemia is not a pleasant thing to have as you experience chest pain, dizziness, tiredness, etc. Hemp has high iron content which makes it highly ideal for treating anemia.
    Hemp can help you get rid of insomnia
    Are you having a hard time getting a peaceful night&rsquo;s sleep? Hemp seed can help you here as it contains a rich amount of magnesium&mdash;a mineral that naturally calms the body and relaxes the muscles.
    hempparadox #cbdhealthbenefits #hemp #welovehemp #welovewhatwedo #cbdwellness

    Hemp is a plant that represents abundance in more ways than one. It grows abundantly with thick, lush green foliage and offers a myriad number of benefits with its high nutrition and therapeutic benefits. Our ancestors realized its benefits thousands of years ago and it is being cultivated since then. Modern research has further attested to this plant&rsquo;s constituents and nutritional profile and the numerous health benefit that it offers. Top 12 medicinal Usages or benefits of hemp. Hemp for your heart Hemp seeds or oil contain an amino acid known as arginine which is extremely good for your heart as it dilates and relaxes your blood vessels. Hemp oil fights inflammation, lowers blood pressure, and prevents the formation of blood clots. Hemp is a rich source of Gamma-Linoleic Acid Hemp seeds are a rich source of gamma-linolenic acid (GLA), which is known for its strong anti-inflammatory properties. Foods rich in GLA are extensively used to fight inflammation in the joints (arthritis), nerve damage, and inflamed skin conditions such as acne, and eczema. Hemp can help you with your stress Hemp seed helps in a variety of diseases. Anxiety caused by pain or health conditions as such can be efficiently dealt with hemp as it can alleviate those conditions. Furthermore, hemp seeds contain an impressive amount of magnesium and B vitamins which can help the body manage stress by impacting neurotransmitters (chemical messenger which transmits signals released by neurons to stimulate other neurons or muscle or gland cells. Protect the brain Studies have found that hemp seed extract has antioxidant effects owing to its cannabidiol (CBD) content which regulates the immune system and could help in neurological conditions such as Parkinson&rsquo;s disease, multiple sclerosis, neuropathic pain, Alzheimer&rsquo;s disease, etc. Improve skin conditions Atopic dermatitis (AD) and acne can both result from chronic inflammation, which results from a deficiency in omega-3. Hemp seeds are a rich source of plant fiber and omega-3 fatty acid along with vitamins such as A and E and minerals such as calcium, iron, zinc, magnesium, and phosphorus, which all help to keep the skin moisturized, soft, supple and disease-free. Repair and regeneration Hemp seeds contain as much protein as soybeans. They provide all nine essential amino acids which are used as building blocks for repair and regeneration across the body. Excellent for the digestive system fibers are excellent for our digestion system. Fibres help in constipation, weight management, nourishment of healthy bacteria in our guts, stabilizes blood sugar level and helps fight cholesterol. Hemp relieves pain Hemp possesses strong anti-inflammatory properties. It is therefore highly useful in relieving pain resulting from an injury, infection or any autoimmunity disorder. Help with Hormones As mentioned above hemp seed contains a rich amount of GLA which can ease hormonal &ldquo;mood swings&rdquo; during periods through stimulation of certain prostaglandins. Relieve rheumatoid arthritis Rheumatoid arthritis refers to inflammation in the joints resulting from immune attacking its tissues. Cannabinoids present in hemp seed oil have anti-rheumatic effects. Effective in treating anemia Anemia is a condition arising out of iron deficiency. Anemia is not a pleasant thing to have as you experience chest pain, dizziness, tiredness, etc. Hemp has high iron content which makes it highly ideal for treating anemia. Hemp can help you get rid of insomnia Are you having a hard time getting a peaceful night&rsquo;s sleep? Hemp seed can help you here as it contains a rich amount of magnesium&mdash;a mineral that naturally calms the body and relaxes the muscles. hempparadox #cbdhealthbenefits #hemp #welovehemp #welovewhatwedo #cbdwellness
    0 Comments 0 Shares 3152 Views